US5182707A - Apparatus for recording reagent test strip data by comparison to color lights on a reference panel - Google Patents

Apparatus for recording reagent test strip data by comparison to color lights on a reference panel Download PDF

Info

Publication number
US5182707A
US5182707A US07/558,062 US55806290A US5182707A US 5182707 A US5182707 A US 5182707A US 55806290 A US55806290 A US 55806290A US 5182707 A US5182707 A US 5182707A
Authority
US
United States
Prior art keywords
color
testing
different
test
strip
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US07/558,062
Inventor
Tommy G. Cooper
Ross E. Smith
Emil S. Macha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Matria Healthcare LLC
Original Assignee
Healthdyne Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Healthdyne Inc filed Critical Healthdyne Inc
Priority to US07/558,062 priority Critical patent/US5182707A/en
Assigned to HEALTHDYNE, INC. reassignment HEALTHDYNE, INC. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: MACHA, EMIL S., SMITH, ROSS E., COOPER, TOMMY G.
Assigned to HEALTHDYNE INC. reassignment HEALTHDYNE INC. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: MACHA, EMIL S., SMITH, ROSS E., COOPER, TOMMY G.
Priority to PCT/US1991/004594 priority patent/WO1992001989A1/en
Publication of US5182707A publication Critical patent/US5182707A/en
Application granted granted Critical
Assigned to CONTINENTAL BANK, N.A. reassignment CONTINENTAL BANK, N.A. SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HEALTHDYNE TECHNOLOGIES, INC.
Assigned to HEALTHDYNE TECHNOLOGIES, INC. reassignment HEALTHDYNE TECHNOLOGIES, INC. RELEASE OF PATENT & TRADEMARK SECURITY AGREEMENT Assignors: CONTINENTAL BANK, N.A.
Assigned to BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION AS AGENT reassignment BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION AS AGENT AMENDED AND RESTATED PATENT AND TRADEMARK SECURITY AGREEMENT Assignors: HEALTHDYNE TECHNOLOGIES, INC.
Assigned to RESPIRONICS GEORGIA, INC. reassignment RESPIRONICS GEORGIA, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: HEALTHDYNE TECHNOLOGIES, INC.
Assigned to MATRIA HEALTHCARE, INC. reassignment MATRIA HEALTHCARE, INC. RELEASE OF SECURITY AGREEMENT Assignors: WACHOVIA BANK, NATIONAL ASSOCIATION F/K/A FIRST UNION NATIONAL BANK, AS AGENT
Assigned to MATRIA HEALTHCARE, INC. reassignment MATRIA HEALTHCARE, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: RESPIRONICS GEORGIA, INC., FORMERLY KNOWN AS HEALTHDYNE TECHNOLOGIES, INC.
Assigned to BANK OF AMERICA, N.A., AS COLLATERAL AGENT reassignment BANK OF AMERICA, N.A., AS COLLATERAL AGENT NOTICE OF GRANT OF SECURITY INTEREST Assignors: MATRIA HEALTHCARE, INC.
Assigned to BANK OF AMERICA, N.A., AS COLLATERAL AGENT reassignment BANK OF AMERICA, N.A., AS COLLATERAL AGENT NOTICE OF GRANT OF SECURITY INTEREST Assignors: MATRIA HEALTHCARE, INC.
Assigned to GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT reassignment GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT SECURITY AGREEMENT Assignors: MATRIA HEALTHCARE, LLC
Assigned to GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT reassignment GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT SECURITY AGREEMENT Assignors: MATRIA HEALTHCARE, LLC
Assigned to MATRIA HEALTHCARE, LLC reassignment MATRIA HEALTHCARE, LLC MERGER (SEE DOCUMENT FOR DETAILS). Assignors: MATRIA HEALTHCARE, INC.
Assigned to MATRIA HEALTHCARE, LLC reassignment MATRIA HEALTHCARE, LLC RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: BANK OF AMERICA, N.A.
Anticipated expiration legal-status Critical
Assigned to GENERAL ELECTRIC CAPITAL CORPORATION reassignment GENERAL ELECTRIC CAPITAL CORPORATION SECURITY AGREEMENT Assignors: ADVANTAGE DIAGNOSTICS CORPORATION, ALERE MEDICAL INCORPORATED, ALERE SAN DIEGO, INC., ALERE SCARBOROUGH, INC., AMEDITECH INC., APPLIED BIOTECH, INC., BINAX, INC., BIOSITE INCORPORATED, CHOLESTECH CORPORATION, GENECARE MEDICAL GENETICS CENTER, INC., HEMOSENSE, INC., INSTANT TECHNOLOGIES, INC., INVERNESS MEDICAL - BIOSTAR INC., ISCHEMIA TECHNOLOGIES, INC., MARTIA HEALTHCARE, INC., MATRITECH, INC., ZYCARE INC.
Assigned to ALERE SCARBOROUGH, INC., BINAX, INC., CHOLESTECH CORPORATION, ISCHEMIA TECHNOLOGIES, INC., ZYCARE, INC., ALERE SAN DIEGO, INC., BIOSITE INCORPORATED, GENECARE MEDICAL GENETICS CENTER, INC., MATRITECH, INC., APPLIED BIOTECH, INC., INSTANT TECHNOLOGIES, INC., ADVANTAGE DIAGNOSTICS CORPORATION, AMEDITECH INC., INVERNESS MEDICAL - BIOSTAR INC., HEMOSENSE, INC., MATRIA HEALTHCARE, INC., ALERE MEDICAL, INC. reassignment ALERE SCARBOROUGH, INC. NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287 Assignors: GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F15/00Digital computers in general; Data processing equipment in general
    • G06F15/02Digital computers in general; Data processing equipment in general manually operated with input through keyboard and computation using a built-in program, e.g. pocket calculators
    • G06F15/025Digital computers in general; Data processing equipment in general manually operated with input through keyboard and computation using a built-in program, e.g. pocket calculators adapted to a specific application

Definitions

  • Test strips usually made of inert plastic or paper having a reagent absorbed on the strip surface for testing the presence or concentration of constituents of a body fluid are commonly used in medical diagnosis and treatment.
  • reagent strip testing of different conditions in urinalysis is used for measuring pH, sugar or glucose, protein, ketone bodies, bilirubin and urobilinogen, hemoglobin, and the like.
  • the reagents on the strip are activated when the strip is exposed to the fluid and given sufficient time to develop, with the reagent developing a color or color intensity corresponding to the presence and/or concentration of the constituent present in the body fluid being tested.
  • reagent test strips are especially beneficial for assisting the management of medication dosage or therapy for patients with chronic diseases, for example, in diabetics for monitoring blood glucose levels in managing insulin therapy, for monitoring urine glucose for screening gestational diabetes and for measuring proteins in toxemia detection during pregnancy.
  • a common method for reading a reagent paper color uses resealable vials having calibrated color areas on the exterior label corresponding to different concentration levels for the tested parameters.
  • the patient inserts the exposed reagent strip into an electronic colorimeter which converts the reagent paper color to a quantitative measurement of the parameter concentration.
  • a disadvantage of such techniques is the requirement of the patient to record the measured information for later review by a clinician or physician.
  • patient compliance for punctual test performance and subsequent reporting is problematic. Often, patients forget to promptly take the test or record the test results accurately.
  • electronic reagent color measuring devices for example, Accu-Check II and Merlin produced by Boehringer-Mannheim Diagnostics provide for improved capture and storing of the reagent test readings, these devices measure only one parameter and thus are not useful for testing a plurality of parameters, which are provided on some reagent papers. Moreover, some electronic reagent color measuring devices require use of a calibration code for each vial of strips and if the code is misplaced, the entire vial of strips is rendered useless.
  • the apparatus of the present invention is designed to obviate the disadvantages of the previously described techniques and devices by providing means for testing, recording, and storing a plurality of different parameters or conditions to be tested on a single reagent test strip.
  • the apparatus incorporates a microcomputer or microcontroller which prompts a user through a sequential series of comparative color measurements to record single or multi-parameter reagent test strip readings. Utilizing visual comparative color discrimination to make the measurement, no calibration is required to compensate for variation in the reagent paper colors.
  • the apparatus includes a replaceable overlay reference panel printed with calibrated color areas preferably arranged in rows and columns corresponding to the color blocks of a particular test strip, and a matrix of lights also preferably arranged in rows and columns, and a microcomputer programmed for directing the user through the sequential operation for easily selecting and recording the test data.
  • the apparatus includes a visual readout or printout capability, and may also be provided with modem and transmission equipment for sending the test data to a remote station for further analysis and drug or medical therapy or prescription by a clinician or physician.
  • FIG. 1 is a front view of an example of a typical reference panel of the apparatus of the invention illustrating features and components thereof;
  • FIG. 2 is a block diagram schematically illustrating components of the apparatus of the invention.
  • FIG. 3 is an operational flow chart further describing the use of the apparatus of the invention.
  • panel 10 of apparatus which illustrates the features and components of the invention used in carrying out the sequential multiple parameter or condition testing.
  • Panel 10 includes a plurality of parameter lights 12, 14, 16 and 18 also sometimes collectively referred to hereinafter as "first lights", arranged preferably in a row for directing sequential testing of different conditions or parameters.
  • Lights 12, 14, 16 and 18 illustrate an example of an apparatus capable of performing and recording tests of four different parameters.
  • the panel also includes a plurality of color spots 30, preferably arranged groups of rows and columns, although other groupings of the color spots may be desired and are within the purview of this invention. In the embodiment shown, the color spots are arranged in parameter test groups of four substantially vertical columns, each column extending below one of the parameter lights 12, 14, 16 or 18.
  • the color spots are also arranged in rows of four, each row composed of the visually distinct and calibrated color spots of the different parameters.
  • color spots 13, 15, 17, 19, 21, 23 and 25 comprise different visually detectable intensity of the same general color for the test parameter of the first test to be carried out and recorded by the apparatus.
  • the specific arrangement of the colors in any one column is not particularly critical, but preferably will be progressive from dark to light color intensity to assist the user or patient in selecting the correct color intensity for that specific parameter test.
  • the color intensity of color spot 13 may be a lighter shade of red than that of color spot 15, which is lighter than color spot 17, etc., or vice versa, if so desired.
  • the color spots need not necessarily be of one color.
  • the reagent color strip uses different colors for that parameter test in addition to different intensities of a single color.
  • Adjacent each color spot 30 is a level light 22, sometimes referred to hereinafter as a "second light".
  • the level light identifies which color spot is being selected during a test procedure, as will be explained more fully hereinafter.
  • the panel 10 also contains a plurality of cavities or spaces 32 one space adjacent each row of color spots for positioning the reagent strip during testing.
  • Each space is preferably sized to be slightly wider than a test strip to allow the strip to be easily positioned into the space.
  • Each space is preferably located adjacent or abutting the lower edge of each row of color spots to assist the user in comparing the colors on the strip against the color spots 30.
  • each color block on the strip will be aligned in the column of color spots to be compared for that particular test parameter. With the groups of color spot columns and rows arranged to correspond to the same spacial arrangement of the color blocks on the test strip, the user will be able to easily compare and identify more precisely and accurately the correct corresponding color or color intensity to be selected in that test parameter procedure.
  • the preferred lights to be used in the matrix of parameter lights 12, 14, 16 and 18 and level lights 22, adjacent each of the different color spots may be light emitting diodes (LED), for example, a green Panasonic LN342GP although any suitable color light may be used.
  • the lights are also preferably rectangular to be consistent with the square shaped color spots and to correspond with the shape of color blocks on a reagent strip.
  • the matrix of lights are used to signal the status of a test in progress, color spot selection and to direct the user sequentially to the test parameters.
  • a parameter light is conveniently flashed on and off to indicate the parameter and column of color spots presently being tested.
  • One of the level lights 22 adjacent a color spot is also preferably flashed on and off during a measurement cycle to indicate the color spot in the column directly above (adjacent) the space in which the test strip has been positioned.
  • the panels may also include a retainer (not shown) for holding a test strip positioned in a space 32.
  • switch 27 is momentarily actuated, and the level light adjacent the selected color spot is turned on continuously. All of the lights are turned on and off under the control of the microcomputer.
  • an optical detector or photointerruptor 34 for detecting the presence of a test strip in the space.
  • a photointerruptor responds only when a strip has been positioned or located in a space.
  • An example of a preferred photointerruptor is a Sharp GP2A11, which is preferably focused for highest sensitivity.
  • a preferred photointerruptor also uses a light modulation technique to eliminate false detection due to high intensity or changes in ambient light levels.
  • the output of the photointerruptor is a discreet, high or low voltage indicating, respectively, detection or nondetection of a strip.
  • the outputs of the photointerruptors 30 are interfaced to the microcomputer which monitors their status.
  • Reference panel 10 also includes switch 27 cooperating with the microcomputer, for turning the apparatus on and off, initiating the test sequence, and to capture and record the color spot selected during the test procedure.
  • switch 27 cooperating with the microcomputer, for turning the apparatus on and off, initiating the test sequence, and to capture and record the color spot selected during the test procedure.
  • the apparatus preferably also includes a timing means cooperating with switch 27 and the microcomputer for terminating the test procedure if the sequential steps are not followed within a prescribed time period and otherwise to prevent error or inaccuracies in carrying out the test procedure within the prescribed program and sequential manner.
  • a status light 28 is also preferably provided adjacent switch 27 for signaling the user of the status of the computer program in the microcomputer and sequential testing.
  • status light 28 flashes for a preselected time period, for example, sixty seconds, to allow and ensure that the reagents in the test strip are fully developed, and to remind the user not to continue testing until the status light stops flashing.
  • a preferred status light will be multi-colored, for example, orange for indicating a pre-selected time delay to be observed by the user, green to indicate that further testing may be continued, and red to signal an error in the test procedure.
  • coloring and operation of such a status light is optional, and other flashing patterns and colors may be used.
  • a second switch 21 may be provided to intentionally terminate a test prior to completion when the user so desires and is preferably a time delay switch requiring actuation for a preselected time period. Such a switch may be conveniently labeled to designate such a function. However, other functions of the procedure may be incorporated into switch 21 if desired, or it may be eliminated.
  • the switches 21, 27 are preferably single contact, momentary action type switches, suitable for fabrication using membrane switch technology. The switches are interfaced to the microcomputer which monitors the switch status as well as operates status light 28. A suitable LED such as a Panasonic LN142WP38 may be used for status light 28.
  • the apparatus of the invention includes a microcomputer suitably including a microcontroller 46 such as a Motorola MC68HC11AO.
  • the microcontroller is programmed for controlling the operational sequence in performing the test functions and recording and storing the data of the completed test results.
  • the program software located in memory 41 such as, for example, an 8K ⁇ 8 EPROM, incorporates a state machine which sequences the program through a series of defined measurement states. As is well known in a state machine, progress from one state to another depends on the current state and set of inputs.
  • the Motorolla MC68HC11 microcomputer 46 an 8-bit machine, is used in the preferred embodiment shown in FIG. 2, and includes integral memory, parallel input/output (I/O) ports, timers, serial I/O ports and other features.
  • a crystal oscillator 47 is used to generate the system clock for the microcomputer.
  • Two of the parallel I/O ports along with an address latch 52 and decode and control circuit 51 are used to form a multiplexed address and data bus for transferring data between the microcontroller and the 8-kilobyte erasable programmable read-only-memory (EPROM) 41 (27C64), the 32-kilobyte static-random-access-memory or (SRAM) 43 (6225), and the real-time clock (RTC) 48 (Dallas Semiconductor DS 1287).
  • the EPROM is used to store the machine code program for the microcomputer.
  • the SRAM is used to store measured data and temporary information.
  • the RTC provides time and date information for storage with each set of measured data.
  • a microprocessor supervisory circuit 45 (Maxim MAX691CPE) is used to provide several functions for ensuring controlled operation of the microcomputer system. It controls the microcomputer reset during power-up, monitors a watchdog interrupt line from the microcontroller for periodic activity, resets the microcontroller if the watchdog interrupt is inactive for more than a predetermined time period, and monitors the unregulated power from a power back-up battery 59 or a DC transformer 55. Upon detection of a low power condition, supervisory circuit 45 will also turn on a low battery light 26 and alert the microcontroller which responds by preventing the start of a new sequence. Supervisory circuit 45 also preferably detects when power is turned off and switches the power to SRAM 43 to a RAM back-up battery 61.
  • the system is designed to operate from AC power or from battery power.
  • the AC power is converted to a DC voltage via the DC transformer.
  • the battery is preferably a rechargeable nickel-cadmium (Nicad) battery.
  • a diode network 62 automatically switches between the two sources.
  • the battery 59 is in a charging mode whenever the DC transformer is providing power.
  • a voltage regulator 58 National Semiconductor LM29403 converts the power from the battery or DC transformer to +5 volts DC to operate the apparatus.
  • the photointerruptors, lights, switches and a speaker 63 on panel 10 are interfaced to microcontroller 46 via the serial-peripheral-interface (SPI) port.
  • SPI serial-peripheral-interface
  • the SPI is an 8-bit register in the microcontroller which simultaneously shifts its contents to the SERIAL OUT line while shifting in information from the SERIAL IN line. The data transfer is synchronized by the CLOCK line.
  • the STRIP and STRIP CLEAR switches and the photointerruptors are interfaced to a set of two 8-bit parallel-to-serial shift registers 56 (74HC165) connected in series.
  • the lights and speaker are interfaced to a set of four 10-bit serial-to-parallel latch drivers 57 (Sprague UCN581OA) connected in series.
  • the microcontroller periodically (for example every 13 milliseconds) requests the SPI to refresh the outputs to the lights and speaker and to input the condition of the switches and photointerruptors.
  • the serial-communications-interface (SCI) port on the microcontroller is a programmable universal asynchronous receive transmit (UART) type port, integral to the microcomputer for sending and receiving data, operating under standard serial communication protocols and frequencies providing a transmit (TXD) and receive (RXD) data lines to interface with an EIA driver 56 (Maxim MAX236CNG) and modem 44 (Sierra Semiconductor SC11004).
  • the EIA driver translates the 5 volt logic levels on the TXD and RXD lines to the voltage levels compatible with a RS232 interface and allows measured data to be transferred to a readout device, such as a personal computer or other type of computer.
  • a modem 44 provides for data communications over a telephone network (not shown).
  • operation and use of the apparatus of the invention is as follows. From an initial state, to start testing at state 1, block 102, the patient or user dips the reagent test strip (not shown) in the body fluid or other material to be tested, such as a sample of urine or blood, and momentarily presses or actuate switch 27 on the panel 10 (FIGS. 1 and 2). At that time, the apparatus is turned on and status light 28 flashes orange for a preselected time period, for example, sixty seconds cycling between 0.5 seconds on and 1.0 seconds off, indicating that the test strip reagent is being developed, and alerting the user that further testing cannot be initiated. Where the apparatus is provided with an audible alarm or signaling means, it may be sounded, to indicate start of the reagent development time delay.
  • state 2 begins and status light 28 turns off, the audible alarm sounds, for example, beeping twice, first parameter light 12 flashes, for example 0.5 seconds on and 0.5 seconds off, and the first column of level lights adjacent color spots 13-25, are activated.
  • the patient observes the reagent strip which by now has developed colors for the different parameters, observing the first parameter, corresponding to the first color block at the left end of the strip, and compares it with the color and/or color intensity of reference panel color spots aligned in the first left hand column below blinking parameter light 12 to determine which of the color spots approximates closest the color and color intensity of the first color block on the strip.
  • the user may move the strip from level to level, i.e., place the strip below different ones of the rows of color spots to examine and compare the color intensity of the strip color block with the color spot on the reference panel.
  • the photointerruptor exposed in the space is activated causing the level light adjacent the color spot in the left hand column to flash synchronously with parameter light 12. For example, if the reagent strip was positioned in space 32 in the first parameter test, level light 24 flashes.
  • parameter light 12 is closest in color and color intensity to the corresponding left end color block of the reagent test strip, and with the strip positioned in the appropriate space directly beneath that selected color spot and the adjacent level light flashing, that color spot is recorded by momentarily pressing switch 27, and level light adjacent the selected color spot stops flashing and remains turned on.
  • Parameter light 12 turns off, and parameter light 14 begins flashing to indicate that the second test parameter is in progress.
  • block 106 the user then observes the second color block of the reagent test strip, and compares it with the second column of color spots below flashing parameter light 14.
  • the user may again move the strip along the rows of color spots on the reference panel to observe the visual color and color intensity distinction and similarity between the color spots in the second column with the second color spot in the test strip.
  • the patient places the test strip in one of the spaces 32, the light adjacent the color spot in the second column directly above the space in which the test strip is positioned flashes.
  • switch 27 When the patient is satisfied that the color spot in the second column most closely compares with the color and intensity of the second color block of the test strip, with that adjacent color spot light flashing, the patient again momentarily actuates switch 27 to record that selected color spot in the apparatus and initiate program state 5, block 108.
  • the flashing level light adjacent the selected color spot is turned on, the second parameter light 14 is turned off, and third color parameter light 16 begins flashing.
  • momentary actuation of switch 27 records the selected color level of the third reagent block and starts state 6, described in block 110.
  • the microcomputer includes a means for energizing the level light adjacent a previously selected color spot in the column of color spots being tested.
  • a means for energizing the level light adjacent a previously selected color spot in the column of color spots being tested For example, if during a previous test the patient had selected color spot 17 in the first parameter test, in the next subsequent test with a parameter light 12 flashing, level light 24 would flash, reminding the patient of the previous selection.
  • switch 27 to record the new selected color spot
  • the level light next to the earlier selected color spot light is turned off and the new level light turned on.
  • the patient when the final parameter has been tested, and the last color spot selected by momentarily pressing switch 27, the patient should observe that a color spot light remains lit in each of the four columns, and that all four of the parameter lights have been turned off.
  • strip light 28 begins flashing green indicating that all of the parameters have been measured.
  • the apparatus may include a means for allowing the user to reconsider and change a selection in any of the parameters.
  • such means may provide for momentarily contacting switch 27 as shown in block 114 whereby first parameter light 12 will flash along with the previously selected color spot light with subsequent momentary contacts of switch 27 causing sequential flashing of reference lights 14, 16 and 18,
  • first parameter light 12 will flash along with the previously selected color spot light with subsequent momentary contacts of switch 27 causing sequential flashing of reference lights 14, 16 and 18,
  • switch 27 may provide for momentarily contacting switch 27 as shown in block 114 whereby first parameter light 12 will flash along with the previously selected color spot light with subsequent momentary contacts of switch 27 causing sequential flashing of reference lights 14, 16 and 18,
  • actuating switch 27 for a preselected length of time other than a momentary actuation, for example two seconds, will terminate the program processing and result in storing of the selections in the microcomputer memory as shown in blocks 112.
  • an audible tone may sound and status light 28 may flash a preselected number of times to indicate successful data storage and termination of the test procedure.
  • the strip read mode is deactivated and returned to the initial state.
  • the apparatus also preferably includes a timer device, for example, real time-clock 48, illustrated in FIG. 2, or a similar means for completing a test, once started, without undue interruptions, which could result in error in reading and comparing the test strip colors with the color spots on the reference panel due to drying, aging, etc.
  • a timer device for example, real time-clock 48, illustrated in FIG. 2, or a similar means for completing a test, once started, without undue interruptions, which could result in error in reading and comparing the test strip colors with the color spots on the reference panel due to drying, aging, etc.
  • RTC 48 cooperating with microcontroller 46 will measure a time for testing at each parameter or condition of a preselected time, for example, sixty seconds to allow the patient to make the selections for each of the respective parameters. If a selection is not made during the sixty seconds, the test is aborted, and the error condition indicated by status light 28 flashing red to so alert the user.
  • An audible indicator may also warble
  • the preferred apparatus also includes a removable and replaceable reference panel cover 11 with the calibrated color spots printed on its face.
  • a removable and replaceable reference panel cover 11 with the calibrated color spots printed on its face.
  • Such a feature may also provide for different tests using different reagent test strips having different color or color intensities for testing different body fluids.
  • a replaceable reference panel cover obviates problems of color spot fading, marking or other deterioration.
  • Reference panel cover 11 includes cut-outs or windows providing exposure of the various matrix lights and test strip spaces or cavities.
  • the apparatus may include means for directly reading the test results incorporating a readout device such as a printer so that the user may have a permanent record of the test results.
  • the apparatus may include or cooperate with modem 44 to convert data signals received from the microcomputer for transmission through telephone lines or otherwise transmitted to a modem and readout or printing device at a remote location, for example, at a clinic, or a physician's office.
  • a remote diagnosis is particularly valuable in saving both physician, technician and patient time not only in testing, but in administering medical care to the patient, especially where immediate care is not required.
  • the apparatus may be designed to test any number of parameters with the appropriate number of reference lights, color response and adjacent level lights being incorporated in the device, along with the appropriate programmed microcomputer. Moreover, the apparatus may be used to test only a single parameter, if desired.

Abstract

An apparatus for recording analysis of a reagent test strip having a plurality of color blocks for testing different constituents of a fluid, comprises a reference panel having a plurality of visually distinguishable and calibrated color areas or spots, a plurality of first lights for designating the testing of a different constituent or parameter, a plurality of second lights each located adjacent a different color spot, a cavity or space adjacent groups of color spots, detection optical detector for detecting the presence of the reagent strip positioned in the space, and a microcomputer for recording and storing test results and having means for directing sequential testing of the different parameters and for turning the lights on and off during the sequential testing. The apparatus includes switches for signaling the microcomputer to record and store the test data and for turning the apparatus on and off. The invention includes a process for operating the apparatus.

Description

BACKGROUND OF THE INVENTION
Test strips, usually made of inert plastic or paper having a reagent absorbed on the strip surface for testing the presence or concentration of constituents of a body fluid are commonly used in medical diagnosis and treatment. For example, reagent strip testing of different conditions in urinalysis is used for measuring pH, sugar or glucose, protein, ketone bodies, bilirubin and urobilinogen, hemoglobin, and the like. The reagents on the strip are activated when the strip is exposed to the fluid and given sufficient time to develop, with the reagent developing a color or color intensity corresponding to the presence and/or concentration of the constituent present in the body fluid being tested. The use of such reagent test strips is especially beneficial for assisting the management of medication dosage or therapy for patients with chronic diseases, for example, in diabetics for monitoring blood glucose levels in managing insulin therapy, for monitoring urine glucose for screening gestational diabetes and for measuring proteins in toxemia detection during pregnancy.
A common method for reading a reagent paper color uses resealable vials having calibrated color areas on the exterior label corresponding to different concentration levels for the tested parameters. In another technique, the patient inserts the exposed reagent strip into an electronic colorimeter which converts the reagent paper color to a quantitative measurement of the parameter concentration. A disadvantage of such techniques is the requirement of the patient to record the measured information for later review by a clinician or physician. Moreover, patient compliance for punctual test performance and subsequent reporting is problematic. Often, patients forget to promptly take the test or record the test results accurately. Although electronic reagent color measuring devices, for example, Accu-Check II and Merlin produced by Boehringer-Mannheim Diagnostics provide for improved capture and storing of the reagent test readings, these devices measure only one parameter and thus are not useful for testing a plurality of parameters, which are provided on some reagent papers. Moreover, some electronic reagent color measuring devices require use of a calibration code for each vial of strips and if the code is misplaced, the entire vial of strips is rendered useless.
SUMMARY OF THE INVENTION
The apparatus of the present invention is designed to obviate the disadvantages of the previously described techniques and devices by providing means for testing, recording, and storing a plurality of different parameters or conditions to be tested on a single reagent test strip. The apparatus incorporates a microcomputer or microcontroller which prompts a user through a sequential series of comparative color measurements to record single or multi-parameter reagent test strip readings. Utilizing visual comparative color discrimination to make the measurement, no calibration is required to compensate for variation in the reagent paper colors. Moreover, the apparatus includes a replaceable overlay reference panel printed with calibrated color areas preferably arranged in rows and columns corresponding to the color blocks of a particular test strip, and a matrix of lights also preferably arranged in rows and columns, and a microcomputer programmed for directing the user through the sequential operation for easily selecting and recording the test data. In the preferred embodiment, the apparatus includes a visual readout or printout capability, and may also be provided with modem and transmission equipment for sending the test data to a remote station for further analysis and drug or medical therapy or prescription by a clinician or physician. These, as well as other advantages, will be evident from the following detailed description.
SUMMARY OF THE DRAWINGS
FIG. 1 is a front view of an example of a typical reference panel of the apparatus of the invention illustrating features and components thereof;
FIG. 2 is a block diagram schematically illustrating components of the apparatus of the invention; and
FIG. 3 is an operational flow chart further describing the use of the apparatus of the invention.
DETAILED DESCRIPTION OF THE INVENTION
Referring first to FIG. 1, panel 10 of apparatus is shown which illustrates the features and components of the invention used in carrying out the sequential multiple parameter or condition testing. Panel 10 includes a plurality of parameter lights 12, 14, 16 and 18 also sometimes collectively referred to hereinafter as "first lights", arranged preferably in a row for directing sequential testing of different conditions or parameters. Lights 12, 14, 16 and 18 illustrate an example of an apparatus capable of performing and recording tests of four different parameters. The panel also includes a plurality of color spots 30, preferably arranged groups of rows and columns, although other groupings of the color spots may be desired and are within the purview of this invention. In the embodiment shown, the color spots are arranged in parameter test groups of four substantially vertical columns, each column extending below one of the parameter lights 12, 14, 16 or 18. The color spots are also arranged in rows of four, each row composed of the visually distinct and calibrated color spots of the different parameters. Thus, for example, under parameter light 12, color spots 13, 15, 17, 19, 21, 23 and 25 comprise different visually detectable intensity of the same general color for the test parameter of the first test to be carried out and recorded by the apparatus. The specific arrangement of the colors in any one column is not particularly critical, but preferably will be progressive from dark to light color intensity to assist the user or patient in selecting the correct color intensity for that specific parameter test. Thus, for example, if the test color block on the reagent strip (not shown) for the first test is red, the color intensity of color spot 13 may be a lighter shade of red than that of color spot 15, which is lighter than color spot 17, etc., or vice versa, if so desired. However, for any given test parameter, the color spots need not necessarily be of one color. For example, the reagent color strip uses different colors for that parameter test in addition to different intensities of a single color.
Adjacent each color spot 30 is a level light 22, sometimes referred to hereinafter as a "second light". The level light identifies which color spot is being selected during a test procedure, as will be explained more fully hereinafter.
The panel 10 also contains a plurality of cavities or spaces 32 one space adjacent each row of color spots for positioning the reagent strip during testing. Each space is preferably sized to be slightly wider than a test strip to allow the strip to be easily positioned into the space. Each space is preferably located adjacent or abutting the lower edge of each row of color spots to assist the user in comparing the colors on the strip against the color spots 30. Moreover, when a test strip is positioned in a space 32, each color block on the strip will be aligned in the column of color spots to be compared for that particular test parameter. With the groups of color spot columns and rows arranged to correspond to the same spacial arrangement of the color blocks on the test strip, the user will be able to easily compare and identify more precisely and accurately the correct corresponding color or color intensity to be selected in that test parameter procedure.
The preferred lights to be used in the matrix of parameter lights 12, 14, 16 and 18 and level lights 22, adjacent each of the different color spots, may be light emitting diodes (LED), for example, a green Panasonic LN342GP although any suitable color light may be used. The lights are also preferably rectangular to be consistent with the square shaped color spots and to correspond with the shape of color blocks on a reagent strip.
The matrix of lights are used to signal the status of a test in progress, color spot selection and to direct the user sequentially to the test parameters. For example, a parameter light is conveniently flashed on and off to indicate the parameter and column of color spots presently being tested. One of the level lights 22 adjacent a color spot is also preferably flashed on and off during a measurement cycle to indicate the color spot in the column directly above (adjacent) the space in which the test strip has been positioned. Thus, when the user places the test strip in a space, the level light adjacent the color spot directly above the test strip in the column of the parameter being tested will also flash. The panels may also include a retainer (not shown) for holding a test strip positioned in a space 32. Once a user has selected a color spot, i.e., finds a color spot that most closely resembles the color block on the strip being tested, switch 27 is momentarily actuated, and the level light adjacent the selected color spot is turned on continuously. All of the lights are turned on and off under the control of the microcomputer.
Cooperating with and preferably exposed in or adjacent each cavity or space 32, is an optical detector or photointerruptor 34 for detecting the presence of a test strip in the space. Such a photointerruptor responds only when a strip has been positioned or located in a space. An example of a preferred photointerruptor is a Sharp GP2A11, which is preferably focused for highest sensitivity. A preferred photointerruptor also uses a light modulation technique to eliminate false detection due to high intensity or changes in ambient light levels. The output of the photointerruptor is a discreet, high or low voltage indicating, respectively, detection or nondetection of a strip. The outputs of the photointerruptors 30 are interfaced to the microcomputer which monitors their status. However, other equivalent means known to those skilled in the art for identifying the presence or absence of a test strip in a respective space may be used. For example, mechanical means such as a cover or similar device which may be moved, for example on a hinge, or otherwise lifted or removed thereby actuating a lever or pin for detecting the presence of a test strip in the space may be used. However, the use of the preferred photointerruptors provides for a most convenient detection of a strip in the space and is preferred in the present apparatus.
Reference panel 10 also includes switch 27 cooperating with the microcomputer, for turning the apparatus on and off, initiating the test sequence, and to capture and record the color spot selected during the test procedure. Although a plurality of different switches could be used for different ones or combinations of such functions, preferably, a single switch 27 is quite suitable and convenient for carrying out the test procedure, as will be further understood hereinafter. The apparatus preferably also includes a timing means cooperating with switch 27 and the microcomputer for terminating the test procedure if the sequential steps are not followed within a prescribed time period and otherwise to prevent error or inaccuracies in carrying out the test procedure within the prescribed program and sequential manner. A status light 28 is also preferably provided adjacent switch 27 for signaling the user of the status of the computer program in the microcomputer and sequential testing. For example, in the preferred embodiment, once the user turns on the apparatus by momentarily actuating switch 27, status light 28 flashes for a preselected time period, for example, sixty seconds, to allow and ensure that the reagents in the test strip are fully developed, and to remind the user not to continue testing until the status light stops flashing. A preferred status light will be multi-colored, for example, orange for indicating a pre-selected time delay to be observed by the user, green to indicate that further testing may be continued, and red to signal an error in the test procedure. However, coloring and operation of such a status light is optional, and other flashing patterns and colors may be used. A second switch 21 may be provided to intentionally terminate a test prior to completion when the user so desires and is preferably a time delay switch requiring actuation for a preselected time period. Such a switch may be conveniently labeled to designate such a function. However, other functions of the procedure may be incorporated into switch 21 if desired, or it may be eliminated. The switches 21, 27 are preferably single contact, momentary action type switches, suitable for fabrication using membrane switch technology. The switches are interfaced to the microcomputer which monitors the switch status as well as operates status light 28. A suitable LED such as a Panasonic LN142WP38 may be used for status light 28.
Referring now to FIG. 2, the apparatus of the invention includes a microcomputer suitably including a microcontroller 46 such as a Motorola MC68HC11AO. The microcontroller is programmed for controlling the operational sequence in performing the test functions and recording and storing the data of the completed test results. The program software located in memory 41 such as, for example, an 8K×8 EPROM, incorporates a state machine which sequences the program through a series of defined measurement states. As is well known in a state machine, progress from one state to another depends on the current state and set of inputs.
The Motorolla MC68HC11 microcomputer 46, an 8-bit machine, is used in the preferred embodiment shown in FIG. 2, and includes integral memory, parallel input/output (I/O) ports, timers, serial I/O ports and other features. A crystal oscillator 47 is used to generate the system clock for the microcomputer. Two of the parallel I/O ports along with an address latch 52 and decode and control circuit 51 are used to form a multiplexed address and data bus for transferring data between the microcontroller and the 8-kilobyte erasable programmable read-only-memory (EPROM) 41 (27C64), the 32-kilobyte static-random-access-memory or (SRAM) 43 (6225), and the real-time clock (RTC) 48 (Dallas Semiconductor DS 1287). The EPROM is used to store the machine code program for the microcomputer. The SRAM is used to store measured data and temporary information. The RTC provides time and date information for storage with each set of measured data.
A microprocessor supervisory circuit 45 (Maxim MAX691CPE) is used to provide several functions for ensuring controlled operation of the microcomputer system. It controls the microcomputer reset during power-up, monitors a watchdog interrupt line from the microcontroller for periodic activity, resets the microcontroller if the watchdog interrupt is inactive for more than a predetermined time period, and monitors the unregulated power from a power back-up battery 59 or a DC transformer 55. Upon detection of a low power condition, supervisory circuit 45 will also turn on a low battery light 26 and alert the microcontroller which responds by preventing the start of a new sequence. Supervisory circuit 45 also preferably detects when power is turned off and switches the power to SRAM 43 to a RAM back-up battery 61.
The system is designed to operate from AC power or from battery power. The AC power is converted to a DC voltage via the DC transformer. The battery is preferably a rechargeable nickel-cadmium (Nicad) battery. A diode network 62 automatically switches between the two sources. The battery 59 is in a charging mode whenever the DC transformer is providing power. A voltage regulator 58 (National Semiconductor LM29403) converts the power from the battery or DC transformer to +5 volts DC to operate the apparatus.
The photointerruptors, lights, switches and a speaker 63 on panel 10 are interfaced to microcontroller 46 via the serial-peripheral-interface (SPI) port. The SPI is an 8-bit register in the microcontroller which simultaneously shifts its contents to the SERIAL OUT line while shifting in information from the SERIAL IN line. The data transfer is synchronized by the CLOCK line. The STRIP and STRIP CLEAR switches and the photointerruptors are interfaced to a set of two 8-bit parallel-to-serial shift registers 56 (74HC165) connected in series. The lights and speaker are interfaced to a set of four 10-bit serial-to-parallel latch drivers 57 (Sprague UCN581OA) connected in series. The microcontroller periodically (for example every 13 milliseconds) requests the SPI to refresh the outputs to the lights and speaker and to input the condition of the switches and photointerruptors.
The serial-communications-interface (SCI) port on the microcontroller is a programmable universal asynchronous receive transmit (UART) type port, integral to the microcomputer for sending and receiving data, operating under standard serial communication protocols and frequencies providing a transmit (TXD) and receive (RXD) data lines to interface with an EIA driver 56 (Maxim MAX236CNG) and modem 44 (Sierra Semiconductor SC11004). The EIA driver translates the 5 volt logic levels on the TXD and RXD lines to the voltage levels compatible with a RS232 interface and allows measured data to be transferred to a readout device, such as a personal computer or other type of computer. A modem 44 provides for data communications over a telephone network (not shown).
Referring also to FIG. 3 of the drawings, operation and use of the apparatus of the invention is as follows. From an initial state, to start testing at state 1, block 102, the patient or user dips the reagent test strip (not shown) in the body fluid or other material to be tested, such as a sample of urine or blood, and momentarily presses or actuate switch 27 on the panel 10 (FIGS. 1 and 2). At that time, the apparatus is turned on and status light 28 flashes orange for a preselected time period, for example, sixty seconds cycling between 0.5 seconds on and 1.0 seconds off, indicating that the test strip reagent is being developed, and alerting the user that further testing cannot be initiated. Where the apparatus is provided with an audible alarm or signaling means, it may be sounded, to indicate start of the reagent development time delay.
At the end of the sixty seconds, state 2 (block 104) begins and status light 28 turns off, the audible alarm sounds, for example, beeping twice, first parameter light 12 flashes, for example 0.5 seconds on and 0.5 seconds off, and the first column of level lights adjacent color spots 13-25, are activated. The patient then observes the reagent strip which by now has developed colors for the different parameters, observing the first parameter, corresponding to the first color block at the left end of the strip, and compares it with the color and/or color intensity of reference panel color spots aligned in the first left hand column below blinking parameter light 12 to determine which of the color spots approximates closest the color and color intensity of the first color block on the strip.
During the visual comparison the user may move the strip from level to level, i.e., place the strip below different ones of the rows of color spots to examine and compare the color intensity of the strip color block with the color spot on the reference panel. During the first parameter test, when the strip is placed in one of the spaces 32, the photointerruptor exposed in the space is activated causing the level light adjacent the color spot in the left hand column to flash synchronously with parameter light 12. For example, if the reagent strip was positioned in space 32 in the first parameter test, level light 24 flashes. Once the user has decided which of the color spots along the column under flashing parameter light 12 is closest in color and color intensity to the corresponding left end color block of the reagent test strip, and with the strip positioned in the appropriate space directly beneath that selected color spot and the adjacent level light flashing, that color spot is recorded by momentarily pressing switch 27, and level light adjacent the selected color spot stops flashing and remains turned on. Parameter light 12 turns off, and parameter light 14 begins flashing to indicate that the second test parameter is in progress.
Moving to state 4, block 106, the user then observes the second color block of the reagent test strip, and compares it with the second column of color spots below flashing parameter light 14. The user may again move the strip along the rows of color spots on the reference panel to observe the visual color and color intensity distinction and similarity between the color spots in the second column with the second color spot in the test strip. When the patient places the test strip in one of the spaces 32, the light adjacent the color spot in the second column directly above the space in which the test strip is positioned flashes. When the patient is satisfied that the color spot in the second column most closely compares with the color and intensity of the second color block of the test strip, with that adjacent color spot light flashing, the patient again momentarily actuates switch 27 to record that selected color spot in the apparatus and initiate program state 5, block 108. The flashing level light adjacent the selected color spot is turned on, the second parameter light 14 is turned off, and third color parameter light 16 begins flashing. Similarly, momentary actuation of switch 27 records the selected color level of the third reagent block and starts state 6, described in block 110. In an apparatus provided with means for testing additional parameters these progressive sequential stages of the program will continue with the patient selecting a color spot in the next successive column beneath the flashing parameter light and matching the color spot with the closest color and color intensity the color block of the reagent test strip as previously described until all of the tests have been completed.
In a preferred embodiment of the apparatus, the microcomputer includes a means for energizing the level light adjacent a previously selected color spot in the column of color spots being tested. Thus, for example, if during a previous test the patient had selected color spot 17 in the first parameter test, in the next subsequent test with a parameter light 12 flashing, level light 24 would flash, reminding the patient of the previous selection. When the patient then selects a different color spot for the first parameter test and actuates switch 27 to record the new selected color spot, the level light next to the earlier selected color spot light is turned off and the new level light turned on.
In the test and apparatus illustrated herein, when the final parameter has been tested, and the last color spot selected by momentarily pressing switch 27, the patient should observe that a color spot light remains lit in each of the four columns, and that all four of the parameter lights have been turned off. In this program state, strip light 28 begins flashing green indicating that all of the parameters have been measured. The apparatus may include a means for allowing the user to reconsider and change a selection in any of the parameters. For example, such means may provide for momentarily contacting switch 27 as shown in block 114 whereby first parameter light 12 will flash along with the previously selected color spot light with subsequent momentary contacts of switch 27 causing sequential flashing of reference lights 14, 16 and 18, To change a previously selected color spot in any of the columns, the user and positions the reagent strip in a space adjacent a new desired color spot in the column under a flashing reference light and momentarily presses switch 27.
When the user is satisfied that all of the selected color spots are correct, actuating switch 27 for a preselected length of time other than a momentary actuation, for example two seconds, will terminate the program processing and result in storing of the selections in the microcomputer memory as shown in blocks 112. At this state, an audible tone may sound and status light 28 may flash a preselected number of times to indicate successful data storage and termination of the test procedure. The strip read mode is deactivated and returned to the initial state.
The apparatus also preferably includes a timer device, for example, real time-clock 48, illustrated in FIG. 2, or a similar means for completing a test, once started, without undue interruptions, which could result in error in reading and comparing the test strip colors with the color spots on the reference panel due to drying, aging, etc. For this purpose, RTC 48 cooperating with microcontroller 46 will measure a time for testing at each parameter or condition of a preselected time, for example, sixty seconds to allow the patient to make the selections for each of the respective parameters. If a selection is not made during the sixty seconds, the test is aborted, and the error condition indicated by status light 28 flashing red to so alert the user. An audible indicator may also warble or otherwise sound continuously and remain activated with the status light on until cleared by the user momentarily pressing switch 27. Thereafter, the program is returned to an initial state and the user may proceed again at the start of the test procedure as previously described.
The preferred apparatus also includes a removable and replaceable reference panel cover 11 with the calibrated color spots printed on its face. Such a feature may also provide for different tests using different reagent test strips having different color or color intensities for testing different body fluids. Also, such a replaceable reference panel cover obviates problems of color spot fading, marking or other deterioration. Reference panel cover 11 includes cut-outs or windows providing exposure of the various matrix lights and test strip spaces or cavities.
As previously noted, the apparatus may include means for directly reading the test results incorporating a readout device such as a printer so that the user may have a permanent record of the test results. In addition, the apparatus may include or cooperate with modem 44 to convert data signals received from the microcomputer for transmission through telephone lines or otherwise transmitted to a modem and readout or printing device at a remote location, for example, at a clinic, or a physician's office. Such a remote diagnosis is particularly valuable in saving both physician, technician and patient time not only in testing, but in administering medical care to the patient, especially where immediate care is not required.
Although the panel shown in the figures and described herein illustrates four parameters or conditions to be tested, the apparatus may be designed to test any number of parameters with the appropriate number of reference lights, color response and adjacent level lights being incorporated in the device, along with the appropriate programmed microcomputer. Moreover, the apparatus may be used to test only a single parameter, if desired. These, as well as other features and modifications within the purview of the invention disclosed herein will be evident to those skilled in the art.

Claims (44)

What is claimed:
1. Apparatus for recording the analysis of a reagent strip having a plurality of color blocks for testing a plurality of different parameters, said apparatus comprising
a panel member including a color chart area comprising a plurality of color groups corresponding to different color blocks of a developed reagent strip, and including two or more set of a plurality of visually distinguishable color spots, each set for testing one of said plurality of different parameters; a plurality of first lights each for signaling the testing of one of said plurality of different parameters; a plurality of second lights each located adjacent a different one of said color spots; and a space adjacent each group of said color spots for positioning said reagent strip and detection means cooperating therewith for detecting said reagent strip in said space;
a microcomputer having means for recording test results for each of said plurality of different parameters, means for directing sequential testing of said plurality of different parameters, and light energizing means for turning said lights on and off during said sequential testing; and
means for recording and storing selected color spots.
2. Apparatus of claim 1 wherein each of said color groups comprises a row of said color spots.
3. Apparatus of claim 2 wherein each of said color spots in a color group is for testing a different parameter.
4. Apparatus of claim 1 wherein each of said sets of color spots is for testing a different one of said different parameters.
5. Apparatus of claim 4 wherein said color chart area comprises two or more rows of said color spots and wherein each different color spot of each of said sets of color spots is located in a different row.
6. Apparatus of claim 5 having a said space and cooperating detection means adjacent to each of said different rows.
7. Apparatus of claim 6 wherein the color spots of each of said sets are aligned generally axially, respectively.
8. Apparatus of claim 7 wherein each of said first lights is aligned axially with the set of color spots for testing one of said different parameters.
9. Apparatus of claim 1 wherein said detection means comprises an optical detector exposed in said space.
10. Apparatus of claim 1 including switching means for turning said apparatus on and for enabling said microcomputer to start said testing.
11. Apparatus of claim 10 including a third light cooperating with said switching means for visually indicating start and termination of said testing.
12. Apparatus of claim 10 including means cooperating with said switching means for delaying said start of the testing for a preselected time delay period after turning the apparatus on.
13. Apparatus of claim 12 including a third light cooperating with said switching means and means for energizing said third light to signal during the preselected time delay period.
14. Apparatus of claim 13 including means for sequentially energizing said first lights for signaling a user to conduct successive tests for said plurality of different parameters.
15. Apparatus of claim 14 including means for energizing a first one of said first lights following said preselected time delay period.
16. Apparatus of claim 14 including means for turning said third light off following the preselected time delay, and for energizing a first one of said first lights when said third light is turned off.
17. Apparatus of claim 16 wherein the color spots of each respective set are aligned substantially axially relative to one of said first lights.
18. Apparatus of claim 16 including means for energizing one of said first lights for signaling said strip in one of said spaces.
19. Apparatus of claim 18 including means for energizing one of said second lights adjacent to a color spot axially aligned with a signaling first light in response to said reagent strip positioned in said space adjacent said color spot.
20. Apparatus of claim 19 wherein said means for recording and storing selected color spots comprises said switching means and said microcomputer.
21. Apparatus of claim 20 including means for signaling completion of testing of all of said different parameters.
22. Apparatus of claim 21 wherein said means for signaling completion of testing comprises said third light.
23. Apparatus of claim 22 including a readout device cooperating with said microcomputer having visual display means for observing results of said testing.
24. Apparatus of claim 22 including a modem cooperating with said microcomputer for transmitting results of said testing and a remote readout device in communication therewith for receiving signals from said modem and having means for visually displaying said results.
25. Apparatus of claim 22 including timer means cooperating with said switching means and said microcomputer for storing data of said selected color spots and turning said apparatus off in response to activation of said switching means for a preselected length of time.
26. Apparatus of claim 1 including a removable panel cover having said color chart imprinted thereon and having a plurality of ports therein for exposing said first and second lights and said spaces.
27. Apparatus of claim 1 including means for sequentially energizing said first lights for signaling a user for successive testing of said different parameters.
28. Apparatus of claim 1 including means for energizing a second light in response to said detection means detecting said reagent strip in said space.
29. Apparatus of claim 1 wherein said microcomputer includes means for energizing one of said second lights for signaling the detection of said strip in a space adjacent to a color spot different than the previous sequentially selected color spot.
30. Apparatus of claim 1 wherein adjacent color spots of each of said sets have a different visually detectable color intensity.
31. Apparatus of claim 1 including a readout device cooperating with said microcomputer having visual display means for observing results of said testing.
32. Apparatus of claim 1 including a printing device cooperating with said microcomputer having means for printing results of said testing.
33. Apparatus of claim 1 including a modem cooperating with said microcomputer for transmitting results of said testing and a remote readout device in communication therewith for receiving signals from said modem and having means for visually displaying said results.
34. Apparatus of claim 1 including means for turning said apparatus off in response to actuation of said switching means for a preselected length of time.
35. Apparatus for testing and recording test results of a reagent test strip having a set of color blocks thereon, each color block for designating a different test parameter, said apparatus comprising:
a reference panel having two or more groups of color spots, each group corresponding to the set of color blocks on said test strip;
a plurality of first signaling means each for designating a different test parameter;
a plurality of second signaling means, each for designating a different color spot;
microcomputer means for sequentially testing said different test parameters and operating said first signaling means sequentially during said testing; and
switching means cooperating with said microcomputer means for recording test results for each of said different test parameters.
36. Apparatus of claim 35 including means for detecting a test strip positioned adjacent to said reference panel.
37. Apparatus of claim 36 including a space adjacent each of said group of color spots for positioning said test strip and wherein said detection means detects said test strip in said space.
38. Process for operating an apparatus of claim 37 comprising exposing said reagent test strip to a composition to be tested, visually comparing the color blocks on said test strip with the color spots on said reference panel, sequentially positioning said test strip in an area adjacent a group of color spots having a color spot most closely approximating the color of a color block of the different test parameters, and sequentially activating said switching means to record the test results of each of said test parameters.
39. Process for operating an apparatus, for testing and recording test results of a reagent test strip having a set of color blocks thereon, each color block for designating a different test parameter, and having a reference panel having two or more groups of color spots, each group corresponding to the set of color blocks on said test strip; a plurality of first signaling means each for designating a different test parameter; a plurality of second signaling means, each for designating a different color spot; microcomputer means for sequentially testing said different test parameters and operating said first signaling means sequentially during said testing; and switching means cooperating with said microcomputer means for recording test results for each of said different test parameters,
said process comprising exposing said reagent test strip to a composition to be tested, visually comparing the color of color blocks thereon with the color spots on said reference panel, and sequentially actuating said switching means for recording the test results for each of said different parameters.
40. A process for testing and recording the test results of a reagent strip having a plurality color blocks thereon, each color block for testing a different parameter of a material, utilizing an apparatus for recording the analysis of a reagent strip having a plurality of color blocks for testing a plurality of different parameters, said apparatus having a panel member including a color chart area comprising a plurality of color groups corresponding to different color blocks of a developed reagent strip, and including two or more sets of a plurality of visually distinguishable color spots, each set for testing one of said plurality of different parameters; a plurality of first lights each for signaling the testing of one or said plurality of different parameters; a plurality of second lights each located adjacent a different one of said color spots; and a space adjacent each group of said color spots for positioning said reagent strip and detection means cooperating therewith for detecting said reagent strip in said space; a microcomputer having means for recording test results for each of said plurality of different parameters, means for directing sequential testing of said plurality of different parameters, light energizing means for turning said lights on and off during said sequential testing; and switching means for turning said apparatus on and for enabling said microcomputer to start said testing; said process comprising:
exposing said testing strip to said material, and actuating said switching means;
visually comparing a first color block with said color spots and positioning said test strip in a space adjacent the color spot having a color intensity visually closest to said first color block color and actuating said switching means;
visually comparing a second color block with said color spots and positioning said test strip in a space adjacent the color spot having a color intensity visually closest to said second color block and actuating said switching means; and
sequentially comparing the color of any remaining color blocks with said color spots, respectively, positioning said test strip in a space adjacent the color spot having a color intensity visually closest to a compared remaining color block, and actuating said switching means, respectively.
41. A reagent strip comparator apparatus, comprising:
a plurality of visual discriminators arranged in a matrix wherein each column of said discriminators defines a parameter and each row of said discriminators defines a condition dependent upon a selected parameter, optical detection means for detecting said reagent strip adjacent to a row of said discriminators, and feedback means responsive to said optical detecting means for signalling the parameter to test.
42. A reagent strip recording apparatus for sequentially testing and recording selected color areas of said reagent strip having an arrangement of visually detectable color areas on said reagent strip, said apparatus comprising a reference panel having a plurality of color spots corresponding to said color areas signalling means for designating sequential testing of said color areas, and switching means and microcomputer means cooperating therewith for recording selected color spots.
43. Apparatus of claim 42 wherein said color spots are arranged in groups corresponding to the arrangement of said color areas.
44. Apparatus of claim 43 including means for signaling sequential recording of selected color spots.
US07/558,062 1990-07-23 1990-07-23 Apparatus for recording reagent test strip data by comparison to color lights on a reference panel Expired - Lifetime US5182707A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US07/558,062 US5182707A (en) 1990-07-23 1990-07-23 Apparatus for recording reagent test strip data by comparison to color lights on a reference panel
PCT/US1991/004594 WO1992001989A1 (en) 1990-07-23 1991-06-28 Apparatus for recording reagent test strip data

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/558,062 US5182707A (en) 1990-07-23 1990-07-23 Apparatus for recording reagent test strip data by comparison to color lights on a reference panel

Publications (1)

Publication Number Publication Date
US5182707A true US5182707A (en) 1993-01-26

Family

ID=24228045

Family Applications (1)

Application Number Title Priority Date Filing Date
US07/558,062 Expired - Lifetime US5182707A (en) 1990-07-23 1990-07-23 Apparatus for recording reagent test strip data by comparison to color lights on a reference panel

Country Status (2)

Country Link
US (1) US5182707A (en)
WO (1) WO1992001989A1 (en)

Cited By (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5307263A (en) * 1992-11-17 1994-04-26 Raya Systems, Inc. Modular microprocessor-based health monitoring system
US5558638A (en) * 1993-04-30 1996-09-24 Healthdyne, Inc. Patient monitor and support system
US5872713A (en) * 1996-10-30 1999-02-16 Mercury Diagnostics, Inc. Synchronized analyte testing system
WO2000022406A2 (en) * 1998-10-13 2000-04-20 Matallana Kielmann Ina Method and device for analyzing reactive strips
US6080106A (en) * 1997-10-28 2000-06-27 Alere Incorporated Patient interface system with a scale
US6168563B1 (en) * 1992-11-17 2001-01-02 Health Hero Network, Inc. Remote health monitoring and maintenance system
US20010011224A1 (en) * 1995-06-07 2001-08-02 Stephen James Brown Modular microprocessor-based health monitoring system
US6377894B1 (en) 1998-11-30 2002-04-23 Abbott Laboratories Analyte test instrument having improved calibration and communication processes
US20030069753A1 (en) * 1992-11-17 2003-04-10 Brown Stephen J. Multi-user remote health monitoring system with biometrics support
US20030097577A1 (en) * 2001-11-20 2003-05-22 Rainbow Technologies, Inc. Software protection method utilizing hidden application code in a protection dynamic link library object
US20030100821A1 (en) * 2001-01-02 2003-05-29 Therasense, Inc. Analyte monitoring device and methods of use
US20030163351A1 (en) * 1997-11-21 2003-08-28 Brown Stephen J. Public health surveillance system
US20030176183A1 (en) * 2001-04-02 2003-09-18 Therasense, Inc. Blood glucose tracking apparatus and methods
US20030187338A1 (en) * 1998-04-30 2003-10-02 Therasense, Inc. Analyte monitoring device and methods of use
US20030192688A1 (en) * 2002-04-10 2003-10-16 Thomson Michael A. Tubing saver rotator and method for using same
US20040019259A1 (en) * 1992-11-17 2004-01-29 Brown Stephen J. Remote monitoring and data management platform
US20040116780A1 (en) * 1992-11-17 2004-06-17 Brown Stephen J. Method and system for improving adherence with a diet program or other medical regimen
US6773671B1 (en) 1998-11-30 2004-08-10 Abbott Laboratories Multichemistry measuring device and test strips
US20040157339A1 (en) * 1997-12-22 2004-08-12 Burke David W. System and method for analyte measurement using AC excitation
US20040157337A1 (en) * 1997-12-22 2004-08-12 Burke David W. System and method for analyte measurement using AC phase angle measurements
US20040186365A1 (en) * 2002-12-31 2004-09-23 Therasense, Inc. Continuous glucose monitoring system and methods of use
US20040199409A1 (en) * 1992-11-17 2004-10-07 Brown Stephen J. Remote health monitoring and maintenance system
US20040219500A1 (en) * 1994-05-23 2004-11-04 Brown Stephen J System and method for remote education using a memory card
US20040256248A1 (en) * 2003-06-20 2004-12-23 Burke David W. System and method for analyte measurement using dose sufficiency electrodes
US20040259180A1 (en) * 2003-06-20 2004-12-23 Burke David W. System and method for analyte measurement employing maximum dosing time delay
US20050003470A1 (en) * 2003-06-10 2005-01-06 Therasense, Inc. Glucose measuring device for use in personal area network
US20050019945A1 (en) * 2003-06-20 2005-01-27 Henning Groll System and method for coding information on a biosensor test strip
US20050027562A1 (en) * 1997-01-16 2005-02-03 Brown Stephen J. Personalized display of health information
US20050060194A1 (en) * 2003-04-04 2005-03-17 Brown Stephen J. Method and system for monitoring health of an individual
US20050118071A1 (en) * 2003-11-15 2005-06-02 Klaus-Dieter Sacherer Dispensing container and storage container for analytical disposables
US20050163657A1 (en) * 2004-01-22 2005-07-28 Childers Winthrop D. Disposable blood test device
US20050228883A1 (en) * 1997-03-28 2005-10-13 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US20050284758A1 (en) * 2004-06-18 2005-12-29 Tom Funke Novel electrode design for biosensor
US20060089969A1 (en) * 1997-03-10 2006-04-27 Health Hero Network, Inc. System and method for modifying documents sent over a communications network
US20060116557A1 (en) * 2004-11-30 2006-06-01 Alere Medical Incorporated Methods and systems for evaluating patient data
US20060155582A1 (en) * 1992-11-17 2006-07-13 Health Hero Network, Inc. Modular microprocessor-based power tool system
US20060241975A1 (en) * 1992-11-17 2006-10-26 Health Hero Network, Inc. Multi-user remote health monitoring system with biometrics support
US20060247508A1 (en) * 2005-04-29 2006-11-02 Therasense, Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US20060253303A1 (en) * 1996-10-16 2006-11-09 Brown Stephen J Multiple patient monitoring system for proactive health management
US20070021984A1 (en) * 2001-03-14 2007-01-25 Health Hero Network, Inc. Interactive patient communication development system for reporting on patient healthcare management
US20070032997A1 (en) * 1997-01-10 2007-02-08 Health Hero Network, Inc. Disease simulation system and method
US20070106135A1 (en) * 2005-11-04 2007-05-10 Abbott Diabetes Care, Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US20070179361A1 (en) * 1992-11-17 2007-08-02 Brown Stephen J Remote health management system
US20070191700A1 (en) * 1998-04-30 2007-08-16 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US20080021436A1 (en) * 1998-04-30 2008-01-24 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US20080033767A1 (en) * 1998-09-25 2008-02-07 Brown Stephen J Dynamic modeling and scoring risk assessment
US20080058625A1 (en) * 2006-06-07 2008-03-06 Abbott Diabetes Care, Inc. Analyte monitoring system and method
US20080200771A1 (en) * 1994-04-26 2008-08-21 Brown Stephen J Treatment regimen compliance and efficacy with feedback
US20080201325A1 (en) * 2007-02-18 2008-08-21 Abbott Diabetes Care, Inc. Method And System For Providing Contextual Based Medication Dosage Determination
US20080201168A1 (en) * 1999-05-03 2008-08-21 Brown Stephen J Treatment regimen compliance and efficacy with feedback
US20080269571A1 (en) * 2003-05-08 2008-10-30 Brown Stephen J Remote health monitoring system
US20080278333A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20080281840A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20090054747A1 (en) * 2005-10-31 2009-02-26 Abbott Diabetes Care, Inc. Method and system for providing analyte sensor tester isolation
US20090054749A1 (en) * 2006-05-31 2009-02-26 Abbott Diabetes Care, Inc. Method and System for Providing Data Transmission in a Data Management System
US7587287B2 (en) 2003-04-04 2009-09-08 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US20090318792A1 (en) * 2007-05-08 2009-12-24 Fennell Martin J Analyte Monitoring System and Methods
US7645373B2 (en) 2003-06-20 2010-01-12 Roche Diagnostic Operations, Inc. System and method for coding information on a biosensor test strip
US7645421B2 (en) 2003-06-20 2010-01-12 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US20100014626A1 (en) * 2007-05-08 2010-01-21 Fennell Martin J Method And Device For Determining Elapsed Sensor Life
US20100045231A1 (en) * 2006-03-31 2010-02-25 Abbott Diabetes Care Inc. Method and System for Powering an Electronic Device
US20100049013A1 (en) * 2007-01-23 2010-02-25 Kevin Chang Analyte-testing device
US20100094111A1 (en) * 1998-04-30 2010-04-15 Abbotte Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US7718439B2 (en) 2003-06-20 2010-05-18 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US20100170807A1 (en) * 2003-06-20 2010-07-08 Diebold Eric R System and method for determining the concentration of an analyte in a sample fluid
US20100191472A1 (en) * 2009-01-29 2010-07-29 Abbott Diabetes Care, Inc. Method and Device for Early Signal Attenuation Using Blood Glucose Measurements
US20100275108A1 (en) * 2009-04-28 2010-10-28 Abbott Diabetes Care Inc. Error Detection in Critical Repeating Data in a Wireless Sensor System
US20100288841A1 (en) * 2009-05-14 2010-11-18 Bayer Healthcare Llc Calibration coded sensors and apparatus, systems and methods for reading same
US20110077494A1 (en) * 2009-09-29 2011-03-31 Abbott Diabetes Care Inc. Method and Apparatus for Providing Notification Function in Analyte Monitoring Systems
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7977112B2 (en) 2003-06-20 2011-07-12 Roche Diagnostics Operations, Inc. System and method for determining an abused sensor during analyte measurement
US8027809B2 (en) 1992-11-17 2011-09-27 Health Hero Network, Inc. Home power management system
US8071384B2 (en) 1997-12-22 2011-12-06 Roche Diagnostics Operations, Inc. Control and calibration solutions and methods for their use
US8078407B1 (en) 1997-03-28 2011-12-13 Health Hero Network, Inc. System and method for identifying disease-influencing genes
US8078431B2 (en) 1992-11-17 2011-12-13 Health Hero Network, Inc. Home power management system
US8095340B2 (en) 1992-11-17 2012-01-10 Health Hero Network, Inc. Home power management system
US8092668B2 (en) 2004-06-18 2012-01-10 Roche Diagnostics Operations, Inc. System and method for quality assurance of a biosensor test strip
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8206565B2 (en) 2003-06-20 2012-06-26 Roche Diagnostics Operation, Inc. System and method for coding information on a biosensor test strip
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8404100B2 (en) 2005-09-30 2013-03-26 Bayer Healthcare Llc Gated voltammetry
US8425757B2 (en) 2005-07-20 2013-04-23 Bayer Healthcare Llc Gated amperometry
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8527206B2 (en) 1999-03-22 2013-09-03 Robert Bosch Gmbh Research data collection and analysis
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20140017802A1 (en) * 2012-07-10 2014-01-16 Fgroupip1, Llc Method to identify chemical compounds using colorimetric spot tests
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8700845B1 (en) * 2009-08-12 2014-04-15 Micron Technology, Inc. Daisy chaining nonvolatile memories
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US9068968B2 (en) 2013-07-02 2015-06-30 Daniel Gordon DRURY Urine analysis device, method and system
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9410917B2 (en) 2004-02-06 2016-08-09 Ascensia Diabetes Care Holdings Ag Method of using a biosensor
US9632055B2 (en) 2010-11-12 2017-04-25 Ascensia Diabetes Care Holdings Ag Auto-coded analyte sensors and apparatus, systems, and methods for detecting same
US9930297B2 (en) 2010-04-30 2018-03-27 Becton, Dickinson And Company System and method for acquiring images of medication preparations
US9933385B2 (en) 2007-12-10 2018-04-03 Ascensia Diabetes Care Holdings Ag Method of using an electrochemical test sensor
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US10417758B1 (en) 2005-02-11 2019-09-17 Becton, Dickinson And Company System and method for remotely supervising and verifying pharmacy functions
US10679342B2 (en) 2014-09-08 2020-06-09 Becton, Dickinson And Company Aerodynamically streamlined enclosure for input devices of a medication preparation system
US11793936B2 (en) 2009-05-29 2023-10-24 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056359A (en) * 1973-04-10 1977-11-01 American Home Products Corporation Profile recognition apparatus for identifying bacteria
US4523852A (en) * 1983-06-09 1985-06-18 Miles Laboratories, Inc. Color comparison reference standard and method for using same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056359A (en) * 1973-04-10 1977-11-01 American Home Products Corporation Profile recognition apparatus for identifying bacteria
US4523852A (en) * 1983-06-09 1985-06-18 Miles Laboratories, Inc. Color comparison reference standard and method for using same

Cited By (449)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060155582A1 (en) * 1992-11-17 2006-07-13 Health Hero Network, Inc. Modular microprocessor-based power tool system
US20060287889A1 (en) * 1992-11-17 2006-12-21 Health Hero Network, Inc. Multi-user remote health monitoring system with biometrics support
US9477939B2 (en) 1992-11-17 2016-10-25 Robert Bosch Healthcare Systems, Inc. Radio frequency based remote health monitoring
US9215979B2 (en) 1992-11-17 2015-12-22 Robert Bosch Healthcare Systems, Inc. Multi-user remote health monitoring system
US20070118588A1 (en) * 1992-11-17 2007-05-24 Brown Stephen J Method and apparatus for remote health monitoring and providing health related information
US8617065B2 (en) 1992-11-17 2013-12-31 Robert Bosch Healthcare Systems, Inc. Networked system for interactive communication and remote monitoring of individuals
US8489428B2 (en) 1992-11-17 2013-07-16 Robert Bosch Healthcare Systems, Inc. Remote health monitoring and maintenance system
US6168563B1 (en) * 1992-11-17 2001-01-02 Health Hero Network, Inc. Remote health monitoring and maintenance system
US8419636B2 (en) 1992-11-17 2013-04-16 Robert Bosch Healthcare Systems, Inc. Method and system for improving adherence with a diet program or other medical regimen
US8407063B2 (en) 1992-11-17 2013-03-26 Robert Bosch Healthcare Systems, Inc. Multi-user remote health monitoring system with biometrics support
US8260630B2 (en) 1992-11-17 2012-09-04 Health Hero Network, Inc. Modular microprocessor-based appliance system
US20070118403A1 (en) * 1992-11-17 2007-05-24 Brown Stephen J Method and apparatus for remote health monitoring and providing health related information
US8249894B2 (en) 1992-11-17 2012-08-21 Robert Bosch Healthcare, Inc. Networked remote patient monitoring with handheld devices
US20120185278A1 (en) * 1992-11-17 2012-07-19 Brown Stephen J Method and apparatus for remote health monitoring and providing health related information
US8095340B2 (en) 1992-11-17 2012-01-10 Health Hero Network, Inc. Home power management system
US8078431B2 (en) 1992-11-17 2011-12-13 Health Hero Network, Inc. Home power management system
US20070118404A1 (en) * 1992-11-17 2007-05-24 Brown Stephen J Method and apparatus for remote health monitoring and providing health related information
US8027809B2 (en) 1992-11-17 2011-09-27 Health Hero Network, Inc. Home power management system
US8024201B2 (en) 1992-11-17 2011-09-20 Health Hero Network, Inc. Method and apparatus for remote health monitoring and providing health related information
US20030229514A2 (en) * 1992-11-17 2003-12-11 Stephen Brown Multi-user remote health monitoring system with biometrics support
US20040019259A1 (en) * 1992-11-17 2004-01-29 Brown Stephen J. Remote monitoring and data management platform
US20040107116A1 (en) * 1992-11-17 2004-06-03 Health Hero Network, Inc. Networked health information system for monitoring food intake
US20040117209A1 (en) * 1992-11-17 2004-06-17 Health Hero Network Patient control of health-related data in a remote patient monitoring system
US20040117207A1 (en) * 1992-11-17 2004-06-17 Health Hero Network, Inc. Report generation in a networked health-monitoring system
US20040116780A1 (en) * 1992-11-17 2004-06-17 Brown Stephen J. Method and system for improving adherence with a diet program or other medical regimen
US20040117210A1 (en) * 1992-11-17 2004-06-17 Health Hero Network Networked remote patient monitoring with handheld devices
US8019618B2 (en) 1992-11-17 2011-09-13 Health Hero Network, Inc. Report generation in a networked health-monitoring system
US20070118589A1 (en) * 1992-11-17 2007-05-24 Brown Stephen J Method and apparatus for remote health monitoring and providing health related information
US8015025B2 (en) 1992-11-17 2011-09-06 Health Hero Network, Inc. Method and apparatus for remote health monitoring and providing health related information
US8015030B2 (en) 1992-11-17 2011-09-06 Health Hero Network, Inc. User-based health monitoring
US20040199409A1 (en) * 1992-11-17 2004-10-07 Brown Stephen J. Remote health monitoring and maintenance system
US7979284B2 (en) 1992-11-17 2011-07-12 Health Hero Network, Inc. Interactive video based remote health monitoring system
US7970620B2 (en) 1992-11-17 2011-06-28 Health Hero Network, Inc. Multi-user remote health monitoring system with biometrics support
US7877274B2 (en) 1992-11-17 2011-01-25 Health Hero Network, Inc. Messaging to remote patients in a networked health-monitoring system
US7941323B2 (en) 1992-11-17 2011-05-10 Health Hero Network, Inc. Remote health monitoring and maintenance system
US7941327B2 (en) 1992-11-17 2011-05-10 Health Hero Network, Inc. User monitoring
US20070094049A1 (en) * 1992-11-17 2007-04-26 Brown Stephen J Method and apparatus for remote health monitoring and providing health related information
US20070016445A1 (en) * 1992-11-17 2007-01-18 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US20030069753A1 (en) * 1992-11-17 2003-04-10 Brown Stephen J. Multi-user remote health monitoring system with biometrics support
US7297109B2 (en) 1992-11-17 2007-11-20 Health Hero Network, Inc. Method and system for improving adherence with a diet program or other medical regimen
US20050086083A1 (en) * 1992-11-17 2005-04-21 Brown Stephen J. User monitoring
US7877276B2 (en) 1992-11-17 2011-01-25 Health Hero Network, Inc. Messaging to remote patients in a networked health-monitoring system
US20070287895A1 (en) * 1992-11-17 2007-12-13 Brown Stephen J System and method for monitoring information from a person
US7853455B2 (en) 1992-11-17 2010-12-14 Health Hero Network, Inc. Remote health monitoring and maintenance system
US7831444B2 (en) 1992-11-17 2010-11-09 Health Hero Network, Inc. Remote health management system
US20050256739A1 (en) * 1992-11-17 2005-11-17 Brown Stephen J Radio frequency based remote health monitoring
US7827040B2 (en) 1992-11-17 2010-11-02 Health Hero Network, Inc. Patient control of health-related data in a remote patient monitoring system
US7765111B2 (en) 1992-11-17 2010-07-27 Health Hero Network, Inc. Method and apparatus for remote health monitoring and providing health related information
US7761312B2 (en) 1992-11-17 2010-07-20 Health Hero Network, Inc. Remote health monitoring and maintenance system
US20060004611A1 (en) * 1992-11-17 2006-01-05 Health Hero Network, Inc. Remote health monitoring and maintenance system
US20060009705A1 (en) * 1992-11-17 2006-01-12 Health Hero Network, Inc. System and method for monitoring air flow from a person
US20060010014A1 (en) * 1992-11-17 2006-01-12 Health Hero Network, Inc. Remote health monitoring and maintenance system
US20060080152A1 (en) * 1992-11-17 2006-04-13 Health Hero Network, Inc. Modular microprocessor-based appliance system
US20100152552A1 (en) * 1992-11-17 2010-06-17 Brown Stephen J User-based health monitoring
US7689440B2 (en) 1992-11-17 2010-03-30 Health Hero Network, Inc. Method and apparatus for remote health monitoring and providing health related information
US20060100910A1 (en) * 1992-11-17 2006-05-11 Health Hero Network, Inc. Interactive video based remote health monitoring system
US7618368B2 (en) 1992-11-17 2009-11-17 Health Hero Network, Inc. System and method for monitoring information from a person
US20070179361A1 (en) * 1992-11-17 2007-08-02 Brown Stephen J Remote health management system
US20060178914A1 (en) * 1992-11-17 2006-08-10 Health Hero Network, Inc. Remote health monitoring and maintenance system
US20060189853A1 (en) * 1992-11-17 2006-08-24 Health Hero Network, Inc. Method and system for improving adherence with a diet program or other medical regimen
US20060247951A1 (en) * 1992-11-17 2006-11-02 Health Hero Network, Inc. Universal serial bus (USB) based remote health monitoring
US20060241975A1 (en) * 1992-11-17 2006-10-26 Health Hero Network, Inc. Multi-user remote health monitoring system with biometrics support
US5307263A (en) * 1992-11-17 1994-04-26 Raya Systems, Inc. Modular microprocessor-based health monitoring system
US5558638A (en) * 1993-04-30 1996-09-24 Healthdyne, Inc. Patient monitor and support system
US7877271B2 (en) 1994-04-26 2011-01-25 Health Hero Network, Inc. Blood glucose monitoring system
US7901625B2 (en) 1994-04-26 2011-03-08 Health Hero Network, Inc. System for performing diabetes self-care
US20070213604A1 (en) * 1994-04-26 2007-09-13 Brown Stephen J Blood glucose monitoring system
US7966230B2 (en) 1994-04-26 2011-06-21 Health Hero Network, Inc. Method and apparatus for remote health monitoring and providing health related information
US20070213608A1 (en) * 1994-04-26 2007-09-13 Brown Stephen J Method and apparatus for remote health monitoring and providing health related information
US20070213605A1 (en) * 1994-04-26 2007-09-13 Brown Stephen J Blood glucose monitoring system
US20080097170A1 (en) * 1994-04-26 2008-04-24 Brown Stephen J Blood glucose monitoring system
US20080200771A1 (en) * 1994-04-26 2008-08-21 Brown Stephen J Treatment regimen compliance and efficacy with feedback
US20080103377A1 (en) * 1994-04-26 2008-05-01 Brown Stephen J System for performing diabetes self-care
US7908152B2 (en) 1994-04-26 2011-03-15 Health Hero Network, Inc. Blood glucose monitoring system
US20070213603A1 (en) * 1994-04-26 2007-09-13 Brown Stephen J Blood glucose monitoring system
US8015033B2 (en) 1994-04-26 2011-09-06 Health Hero Network, Inc. Treatment regimen compliance and efficacy with feedback
US8032399B2 (en) 1994-04-26 2011-10-04 Health Hero Network, Inc. Treatment regimen compliance and efficacy with feedback
US7904310B2 (en) 1994-04-26 2011-03-08 Health Hero Network, Inc. Blood glucose monitoring system
US9123083B2 (en) 1994-04-26 2015-09-01 Robert Bosch Healthcare Systems, Inc. Blood glucose monitoring system
US20080109172A1 (en) * 1994-05-23 2008-05-08 Brown Stephen J Diabetes management system
US20040219500A1 (en) * 1994-05-23 2004-11-04 Brown Stephen J System and method for remote education using a memory card
US20080103379A1 (en) * 1994-05-23 2008-05-01 Brown Stephen J Diabetes management system
US20060234202A1 (en) * 1994-05-23 2006-10-19 Health Hero Network, Inc. System and method for monitoring a physiological condition
US20080097181A1 (en) * 1994-05-23 2008-04-24 Brown Stephen J Diabetes management system
US7972267B2 (en) 1994-05-23 2011-07-05 Health Hero Network, Inc. Diabetes management system
US8616895B2 (en) 1994-05-23 2013-12-31 Robert Bosch Healthcare Systems, Inc. System and method for monitoring a physiological condition
US20070212671A1 (en) * 1994-05-23 2007-09-13 Brown Stephen J System and method for monitoring a physiological condition
US7871376B2 (en) 1994-05-23 2011-01-18 Health Hero Network, Inc. System and method for monitoring a physiological condition
US7862506B2 (en) 1994-05-23 2011-01-04 Health Hero Network, Inc. Diabetes management system
US7867165B2 (en) 1994-05-23 2011-01-11 Health Hero Network, Inc. System and method for monitoring a physiological condition
US7869852B2 (en) 1994-05-23 2011-01-11 Health Hero Network, Inc. Diabetes management system
US8655259B2 (en) 1994-05-23 2014-02-18 Robert Bosch Healthcare Systems, Inc. System and method for monitoring a physiological condition
US7684999B2 (en) 1995-06-07 2010-03-23 Health Hero Network, Inc. User-based health monitoring
US20010011224A1 (en) * 1995-06-07 2001-08-02 Stephen James Brown Modular microprocessor-based health monitoring system
US20050080652A1 (en) * 1995-06-07 2005-04-14 Brown Stephen J. User-based health monitoring
US20090112624A1 (en) * 1996-10-16 2009-04-30 Brown Stephen J Multiple patient monitoring system for proactive health management
US20100205003A1 (en) * 1996-10-16 2010-08-12 Health Hero Network, Inc. Multiple patient monitoring system for proactive health management
US7769605B2 (en) 1996-10-16 2010-08-03 Health Hero Network, Inc. Multiple patient monitoring system for proactive health management
US7765112B2 (en) 1996-10-16 2010-07-27 Health Hero Network, Inc. Multiple patient monitoring system for proactive health management
US20070299326A1 (en) * 1996-10-16 2007-12-27 Brown Stephen J Multiple patient monitoring system for proactive health management
US7840420B2 (en) 1996-10-16 2010-11-23 Health Hero Network, Inc. Multiple patient monitoring system for proactive health management
US7778845B2 (en) 1996-10-16 2010-08-17 Health Hero Network, Inc. Multiple patient monitoring system for proactive health management
US20060253303A1 (en) * 1996-10-16 2006-11-09 Brown Stephen J Multiple patient monitoring system for proactive health management
US6106780A (en) * 1996-10-30 2000-08-22 Amira Medical Synchronized analyte testing system
US5872713A (en) * 1996-10-30 1999-02-16 Mercury Diagnostics, Inc. Synchronized analyte testing system
US6544475B1 (en) 1996-10-30 2003-04-08 Amira Medical Synchronized analyte testing system
US20070032997A1 (en) * 1997-01-10 2007-02-08 Health Hero Network, Inc. Disease simulation system and method
USRE43316E1 (en) 1997-01-10 2012-04-17 Health Hero Network, Inc. Diabetes management system and method for controlling blood glucose
US20070078681A1 (en) * 1997-01-10 2007-04-05 Brown Stephen J Disease simulation system and method
US7925522B2 (en) 1997-01-16 2011-04-12 Health Hero Network, Inc. Personalized body image
US20050027562A1 (en) * 1997-01-16 2005-02-03 Brown Stephen J. Personalized display of health information
US20060089969A1 (en) * 1997-03-10 2006-04-27 Health Hero Network, Inc. System and method for modifying documents sent over a communications network
US7814143B2 (en) 1997-03-10 2010-10-12 Health Hero Network, Inc. System and method for modifying documents sent over a communications network
US20100274835A1 (en) * 1997-03-28 2010-10-28 Brown Stephen J Remote monitoring for education, security, and inventory
US8870762B2 (en) 1997-03-28 2014-10-28 Robert Bosch Gmbh Electronic data capture in clinical and pharmaceutical trials
US20070156893A1 (en) * 1997-03-28 2007-07-05 Brown Stephen J Drug marketing and development tool
US7730177B2 (en) 1997-03-28 2010-06-01 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US7734718B2 (en) 1997-03-28 2010-06-08 Health Hero Network, Inc. Smart appliance functionality
US7987100B2 (en) 1997-03-28 2011-07-26 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US20060252089A1 (en) * 1997-03-28 2006-11-09 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US20070011320A1 (en) * 1997-03-28 2007-01-11 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US8078407B1 (en) 1997-03-28 2011-12-13 Health Hero Network, Inc. System and method for identifying disease-influencing genes
US7921186B2 (en) 1997-03-28 2011-04-05 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US20060253574A1 (en) * 1997-03-28 2006-11-09 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US7707270B2 (en) 1997-03-28 2010-04-27 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US8353827B2 (en) 1997-03-28 2013-01-15 Robert Bosch Healthcare Systems, Inc. Networked system for interactive communication and remote monitoring of individuals
US20070156892A1 (en) * 1997-03-28 2007-07-05 Brown Stephen J Smart appliance functionality
US7870249B2 (en) 1997-03-28 2011-01-11 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US8608653B2 (en) 1997-03-28 2013-12-17 Robert Bosch Gmbh Networked system for interactive communication and remote monitoring of individuals
US20070124466A1 (en) * 1997-03-28 2007-05-31 Brown Stephen J Audio instructions for appliances
US8959198B2 (en) 1997-03-28 2015-02-17 Robert Bosch Healthcare Systems, Inc. Optimizing oxygen tank deliver or refills for COPD patients through measurement of blood oxygen levels
US20050228883A1 (en) * 1997-03-28 2005-10-13 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US20070168242A1 (en) * 1997-03-28 2007-07-19 Brown Stephen J Networked system for interactive communication and remote monitoring of pharmaceutical manufacturer and clinical trials
US6968375B1 (en) 1997-03-28 2005-11-22 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US8140663B2 (en) 1997-03-28 2012-03-20 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US7822625B2 (en) 1997-03-28 2010-10-26 Health Hero Network, Inc. Networked system for interactive communication and remote monitoring of individuals
US20070135688A1 (en) * 1997-03-28 2007-06-14 Brown Stephen J Networked system for interactive communication and remote monitoring of individuals
US20070168504A1 (en) * 1997-03-28 2007-07-19 Brown Stephen J Optimizing oxygen tank deliver or refills for copd patients through measurement of blood oxygen levels
US8990336B2 (en) 1997-03-28 2015-03-24 Robert Bosch Healthcare Systems, Inc. Networked system for interactive communication and remote monitoring of individuals
US6080106A (en) * 1997-10-28 2000-06-27 Alere Incorporated Patient interface system with a scale
US8626521B2 (en) 1997-11-21 2014-01-07 Robert Bosch Healthcare Systems, Inc. Public health surveillance system
US20030163351A1 (en) * 1997-11-21 2003-08-28 Brown Stephen J. Public health surveillance system
US20040157337A1 (en) * 1997-12-22 2004-08-12 Burke David W. System and method for analyte measurement using AC phase angle measurements
US20040157339A1 (en) * 1997-12-22 2004-08-12 Burke David W. System and method for analyte measurement using AC excitation
US8071384B2 (en) 1997-12-22 2011-12-06 Roche Diagnostics Operations, Inc. Control and calibration solutions and methods for their use
US8275439B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20090177057A1 (en) * 1998-04-30 2009-07-09 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US20100094111A1 (en) * 1998-04-30 2010-04-15 Abbotte Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US10478108B2 (en) 1998-04-30 2019-11-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20070149873A1 (en) * 1998-04-30 2007-06-28 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US9326714B2 (en) 1998-04-30 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20070161879A1 (en) * 1998-04-30 2007-07-12 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US9072477B2 (en) 1998-04-30 2015-07-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066694B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20100069729A1 (en) * 1998-04-30 2010-03-18 James Say Analyte Monitoring Device And Methods Of Use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066697B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20100168659A1 (en) * 1998-04-30 2010-07-01 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US20100168658A1 (en) * 1998-04-30 2010-07-01 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US9042953B2 (en) 1998-04-30 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011331B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9014773B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20070161880A1 (en) * 1998-04-30 2007-07-12 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20070179372A1 (en) * 1998-04-30 2007-08-02 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US8880137B2 (en) 1998-04-30 2014-11-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20070191700A1 (en) * 1998-04-30 2007-08-16 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US8840553B2 (en) 1998-04-30 2014-09-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8774887B2 (en) 1998-04-30 2014-07-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20100234709A1 (en) * 1998-04-30 2010-09-16 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US8744545B2 (en) 1998-04-30 2014-06-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734346B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20100268050A1 (en) * 1998-04-30 2010-10-21 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US20100268044A1 (en) * 1998-04-30 2010-10-21 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US20100268045A1 (en) * 1998-04-30 2010-10-21 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US20100268046A1 (en) * 1998-04-30 2010-10-21 James Say Analyte Monitoring Device and Methods of Use
US8734348B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8738109B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20090292189A1 (en) * 1998-04-30 2009-11-26 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US8672844B2 (en) 1998-04-30 2014-03-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20100292553A1 (en) * 1998-04-30 2010-11-18 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US8670815B2 (en) 1998-04-30 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8666469B2 (en) 1998-04-30 2014-03-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8660627B2 (en) 1998-04-30 2014-02-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20070213610A1 (en) * 1998-04-30 2007-09-13 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US20100324400A1 (en) * 1998-04-30 2010-12-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20100324399A1 (en) * 1998-04-30 2010-12-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7860544B2 (en) 1998-04-30 2010-12-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8649841B2 (en) 1998-04-30 2014-02-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20090216101A1 (en) * 1998-04-30 2009-08-27 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US7869853B1 (en) 1998-04-30 2011-01-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20090187090A1 (en) * 1998-04-30 2009-07-23 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US20090182215A1 (en) * 1998-04-30 2009-07-16 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US8162829B2 (en) 1998-04-30 2012-04-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20110011399A1 (en) * 1998-04-30 2011-01-20 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US20110015510A1 (en) * 1998-04-30 2011-01-20 Abbott Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US20050199494A1 (en) * 1998-04-30 2005-09-15 James Say Analyte monitoring device and methods of use
US8641619B2 (en) 1998-04-30 2014-02-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8622906B2 (en) 1998-04-30 2014-01-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7885699B2 (en) 1998-04-30 2011-02-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8617071B2 (en) 1998-04-30 2013-12-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20090173628A1 (en) * 1998-04-30 2009-07-09 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20080021436A1 (en) * 1998-04-30 2008-01-24 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US8597189B2 (en) 1998-04-30 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8473021B2 (en) 1998-04-30 2013-06-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8409131B2 (en) 1998-04-30 2013-04-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8175673B2 (en) 1998-04-30 2012-05-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8177716B2 (en) 1998-04-30 2012-05-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8224413B2 (en) 1998-04-30 2012-07-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226555B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226558B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8391945B2 (en) 1998-04-30 2013-03-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8380273B2 (en) 1998-04-30 2013-02-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8372005B2 (en) 1998-04-30 2013-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8366614B2 (en) 1998-04-30 2013-02-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8357091B2 (en) 1998-04-30 2013-01-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226557B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8353829B2 (en) 1998-04-30 2013-01-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20080262329A1 (en) * 1998-04-30 2008-10-23 Abbott Diabetes Care, Inc. Analyte Monitoring Device and Methods of Use
US8346336B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8231532B2 (en) 1998-04-30 2012-07-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20030187338A1 (en) * 1998-04-30 2003-10-02 Therasense, Inc. Analyte monitoring device and methods of use
US8306598B2 (en) 1998-04-30 2012-11-06 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8287454B2 (en) 1998-04-30 2012-10-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8273022B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8265726B2 (en) 1998-04-30 2012-09-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20080167543A1 (en) * 1998-04-30 2008-07-10 Abbott Diabetes Care, Inc. Analyte Monitoring Device And Methods Of Use
US8260392B2 (en) 1998-04-30 2012-09-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8255031B2 (en) 1998-04-30 2012-08-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8235896B2 (en) 1998-04-30 2012-08-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8005690B2 (en) 1998-09-25 2011-08-23 Health Hero Network, Inc. Dynamic modeling and scoring risk assessment
US20080033767A1 (en) * 1998-09-25 2008-02-07 Brown Stephen J Dynamic modeling and scoring risk assessment
US8521546B2 (en) 1998-09-25 2013-08-27 Health Hero Network Dynamic modeling and scoring risk assessment
WO2000022406A3 (en) * 1998-10-13 2000-10-12 Matallana Kielmann Ina Method and device for analyzing reactive strips
WO2000022406A2 (en) * 1998-10-13 2000-04-20 Matallana Kielmann Ina Method and device for analyzing reactive strips
US6600997B2 (en) 1998-11-30 2003-07-29 Abbott Laboratories Analyte test instrument having improved calibration and communication processes
US6773671B1 (en) 1998-11-30 2004-08-10 Abbott Laboratories Multichemistry measuring device and test strips
US6377894B1 (en) 1998-11-30 2002-04-23 Abbott Laboratories Analyte test instrument having improved calibration and communication processes
US8527206B2 (en) 1999-03-22 2013-09-03 Robert Bosch Gmbh Research data collection and analysis
US20080201168A1 (en) * 1999-05-03 2008-08-21 Brown Stephen J Treatment regimen compliance and efficacy with feedback
US20080086040A1 (en) * 2001-01-02 2008-04-10 Abbott Diabetes Care, Inc. Analyte Monitoring Device And Methods Of Use
US9610034B2 (en) 2001-01-02 2017-04-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20080086041A1 (en) * 2001-01-02 2008-04-10 Abbott Diabetes Care, Inc. Analyte Monitoring Device And Methods Of Use
US9498159B2 (en) 2001-01-02 2016-11-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20030100821A1 (en) * 2001-01-02 2003-05-29 Therasense, Inc. Analyte monitoring device and methods of use
US9011332B2 (en) 2001-01-02 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20080091095A1 (en) * 2001-01-02 2008-04-17 Abbott Diabetes Care, Inc. Analyte Monitoring Device And Methods Of Use
US8668645B2 (en) 2001-01-02 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20080086043A1 (en) * 2001-01-02 2008-04-10 Abbott Diabetes Care, Inc. Analyte Monitoring Device And Methods Of Use
US8652043B2 (en) 2001-01-02 2014-02-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20070021984A1 (en) * 2001-03-14 2007-01-25 Health Hero Network, Inc. Interactive patient communication development system for reporting on patient healthcare management
US20100145733A1 (en) * 2001-04-02 2010-06-10 Abbott Diabetes Care Inc. Blood Glucose Tracking Apparatus and Methods
US7041468B2 (en) 2001-04-02 2006-05-09 Therasense, Inc. Blood glucose tracking apparatus and methods
US7976778B2 (en) 2001-04-02 2011-07-12 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US8236242B2 (en) 2001-04-02 2012-08-07 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US20100068796A1 (en) * 2001-04-02 2010-03-18 Abbott Diabetes Care Inc. Blood Glucose Tracking Apparatus and Methods
US20100098583A1 (en) * 2001-04-02 2010-04-22 Abbott Diabetes Care Inc. Blood Glucose Tracking Apparatus and Methods
US8268243B2 (en) 2001-04-02 2012-09-18 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US8765059B2 (en) 2001-04-02 2014-07-01 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US20100311151A1 (en) * 2001-04-02 2010-12-09 Abbott Diabetes Care Inc. Blood Glucose Tracking Apparatus and Methods
US20050277164A1 (en) * 2001-04-02 2005-12-15 Therasense, Inc. Blood glucose tracking apparatus and methods
US9477811B2 (en) 2001-04-02 2016-10-25 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US20100100580A1 (en) * 2001-04-02 2010-04-22 Abbott Diabetes Care Inc. Blood Glucose Tracking Apparatus and Methods
US20030176183A1 (en) * 2001-04-02 2003-09-18 Therasense, Inc. Blood glucose tracking apparatus and methods
US20050239156A1 (en) * 2001-04-02 2005-10-27 Therasense, Inc. Blood glucose tracking apparatus and methods
US20030097577A1 (en) * 2001-11-20 2003-05-22 Rainbow Technologies, Inc. Software protection method utilizing hidden application code in a protection dynamic link library object
US7320075B2 (en) * 2001-11-20 2008-01-15 Safenet, Inc. Software protection method utilizing hidden application code in a protection dynamic link library object
US20030192688A1 (en) * 2002-04-10 2003-10-16 Thomson Michael A. Tubing saver rotator and method for using same
US8622903B2 (en) 2002-12-31 2014-01-07 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US10750952B2 (en) 2002-12-31 2020-08-25 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US9962091B2 (en) 2002-12-31 2018-05-08 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8187183B2 (en) 2002-12-31 2012-05-29 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US10039881B2 (en) 2002-12-31 2018-08-07 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US20040186365A1 (en) * 2002-12-31 2004-09-23 Therasense, Inc. Continuous glucose monitoring system and methods of use
US8682598B2 (en) 2003-04-04 2014-03-25 Abbott Laboratories Method and system for transferring analyte test data
US8483974B2 (en) 2003-04-04 2013-07-09 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US20100076288A1 (en) * 2003-04-04 2010-03-25 Brian Edmond Connolly Method and System for Transferring Analyte Test Data
US20100121168A1 (en) * 2003-04-04 2010-05-13 Abbott Diabetes Care Inc. Method and System for Transferring Analyte Test Data
US8437966B2 (en) 2003-04-04 2013-05-07 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US8560250B2 (en) 2003-04-04 2013-10-15 Abbott Laboratories Method and system for transferring analyte test data
US7587287B2 (en) 2003-04-04 2009-09-08 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US20050060194A1 (en) * 2003-04-04 2005-03-17 Brown Stephen J. Method and system for monitoring health of an individual
US8945009B2 (en) 2003-05-08 2015-02-03 Robert Bosch Heathcare Systems, Inc. Remote health monitoring system
US20080269571A1 (en) * 2003-05-08 2008-10-30 Brown Stephen J Remote health monitoring system
US9730584B2 (en) 2003-06-10 2017-08-15 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US20110046469A1 (en) * 2003-06-10 2011-02-24 Abbott Diabetes Care Inc. Glucose Measuring Device for Use In Personal Area Network
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8647269B2 (en) 2003-06-10 2014-02-11 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US20050003470A1 (en) * 2003-06-10 2005-01-06 Therasense, Inc. Glucose measuring device for use in personal area network
US8512239B2 (en) 2003-06-10 2013-08-20 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8298828B2 (en) 2003-06-20 2012-10-30 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US8293538B2 (en) 2003-06-20 2012-10-23 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US7645421B2 (en) 2003-06-20 2010-01-12 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US20040259180A1 (en) * 2003-06-20 2004-12-23 Burke David W. System and method for analyte measurement employing maximum dosing time delay
US8586373B2 (en) 2003-06-20 2013-11-19 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US8507289B1 (en) 2003-06-20 2013-08-13 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US20100111764A1 (en) * 2003-06-20 2010-05-06 Henning Groll System and method for coding information on a biosensor test strip
US7977112B2 (en) 2003-06-20 2011-07-12 Roche Diagnostics Operations, Inc. System and method for determining an abused sensor during analyte measurement
US7645373B2 (en) 2003-06-20 2010-01-12 Roche Diagnostic Operations, Inc. System and method for coding information on a biosensor test strip
US7718439B2 (en) 2003-06-20 2010-05-18 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US20090045076A1 (en) * 2003-06-20 2009-02-19 Burke David W System and method for analyte measurement using dose sufficiency electrodes
US8058077B2 (en) 2003-06-20 2011-11-15 Roche Diagnostics Operations, Inc. Method for coding information on a biosensor test strip
US20050019945A1 (en) * 2003-06-20 2005-01-27 Henning Groll System and method for coding information on a biosensor test strip
US8663442B2 (en) 2003-06-20 2014-03-04 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US8859293B2 (en) 2003-06-20 2014-10-14 Roche Diagnostics Operations, Inc. Method for determining whether a disposable, dry regent, electrochemical test strip is unsuitable for use
US8206565B2 (en) 2003-06-20 2012-06-26 Roche Diagnostics Operation, Inc. System and method for coding information on a biosensor test strip
US20100170807A1 (en) * 2003-06-20 2010-07-08 Diebold Eric R System and method for determining the concentration of an analyte in a sample fluid
US8083993B2 (en) 2003-06-20 2011-12-27 Riche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US8148164B2 (en) 2003-06-20 2012-04-03 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US20040256248A1 (en) * 2003-06-20 2004-12-23 Burke David W. System and method for analyte measurement using dose sufficiency electrodes
US7670562B2 (en) 2003-11-15 2010-03-02 Roche Diagnostics Operations, Inc. Dispensing container and storage container for analytical disposables
US20050118071A1 (en) * 2003-11-15 2005-06-02 Klaus-Dieter Sacherer Dispensing container and storage container for analytical disposables
US7776559B2 (en) 2004-01-22 2010-08-17 Hewlett-Packard Development Company, L.P. Disposable blood test device
US20050163657A1 (en) * 2004-01-22 2005-07-28 Childers Winthrop D. Disposable blood test device
US10067082B2 (en) 2004-02-06 2018-09-04 Ascensia Diabetes Care Holdings Ag Biosensor for determining an analyte concentration
US9410917B2 (en) 2004-02-06 2016-08-09 Ascensia Diabetes Care Holdings Ag Method of using a biosensor
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US20050284758A1 (en) * 2004-06-18 2005-12-29 Tom Funke Novel electrode design for biosensor
US9410915B2 (en) 2004-06-18 2016-08-09 Roche Operations Ltd. System and method for quality assurance of a biosensor test strip
US8092668B2 (en) 2004-06-18 2012-01-10 Roche Diagnostics Operations, Inc. System and method for quality assurance of a biosensor test strip
US20060116557A1 (en) * 2004-11-30 2006-06-01 Alere Medical Incorporated Methods and systems for evaluating patient data
US10417758B1 (en) 2005-02-11 2019-09-17 Becton, Dickinson And Company System and method for remotely supervising and verifying pharmacy functions
US20060247508A1 (en) * 2005-04-29 2006-11-02 Therasense, Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US8425757B2 (en) 2005-07-20 2013-04-23 Bayer Healthcare Llc Gated amperometry
US8877035B2 (en) 2005-07-20 2014-11-04 Bayer Healthcare Llc Gated amperometry methods
US8647489B2 (en) 2005-09-30 2014-02-11 Bayer Healthcare Llc Gated voltammetry devices
US9835582B2 (en) 2005-09-30 2017-12-05 Ascensia Diabetes Care Holdings Ag Devices using gated voltammetry methods
US10670553B2 (en) 2005-09-30 2020-06-02 Ascensia Diabetes Care Holdings Ag Devices using gated voltammetry methods
US8404100B2 (en) 2005-09-30 2013-03-26 Bayer Healthcare Llc Gated voltammetry
US9110013B2 (en) 2005-09-30 2015-08-18 Bayer Healthcare Llc Gated voltammetry methods
US11435312B2 (en) 2005-09-30 2022-09-06 Ascensia Diabetes Care Holdings Ag Devices using gated voltammetry methods
US20090054747A1 (en) * 2005-10-31 2009-02-26 Abbott Diabetes Care, Inc. Method and system for providing analyte sensor tester isolation
US8920319B2 (en) 2005-11-01 2014-12-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11272867B2 (en) 2005-11-01 2022-03-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11911151B1 (en) 2005-11-01 2024-02-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10231654B2 (en) 2005-11-01 2019-03-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10952652B2 (en) 2005-11-01 2021-03-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326716B2 (en) 2005-11-01 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8915850B2 (en) 2005-11-01 2014-12-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11399748B2 (en) 2005-11-01 2022-08-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11103165B2 (en) 2005-11-01 2021-08-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10201301B2 (en) 2005-11-01 2019-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9078607B2 (en) 2005-11-01 2015-07-14 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11363975B2 (en) 2005-11-01 2022-06-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9323898B2 (en) 2005-11-04 2016-04-26 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US20070106135A1 (en) * 2005-11-04 2007-05-10 Abbott Diabetes Care, Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US9669162B2 (en) 2005-11-04 2017-06-06 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8585591B2 (en) 2005-11-04 2013-11-19 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US11538580B2 (en) 2005-11-04 2022-12-27 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US9039975B2 (en) 2006-03-31 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8597575B2 (en) 2006-03-31 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8593109B2 (en) 2006-03-31 2013-11-26 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US9380971B2 (en) 2006-03-31 2016-07-05 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US9625413B2 (en) 2006-03-31 2017-04-18 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US20100045231A1 (en) * 2006-03-31 2010-02-25 Abbott Diabetes Care Inc. Method and System for Powering an Electronic Device
US8933664B2 (en) 2006-03-31 2015-01-13 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US9743863B2 (en) 2006-03-31 2017-08-29 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US20090054749A1 (en) * 2006-05-31 2009-02-26 Abbott Diabetes Care, Inc. Method and System for Providing Data Transmission in a Data Management System
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US20090281406A1 (en) * 2006-06-07 2009-11-12 Abbott Diabetes Care Inc. Analyte Monitoring System and Method
US20080058625A1 (en) * 2006-06-07 2008-03-06 Abbott Diabetes Care, Inc. Analyte monitoring system and method
US9305138B2 (en) 2007-01-23 2016-04-05 Ascensia Diabetes Care Holdings Ag Analyte-testing device
US9092557B2 (en) 2007-01-23 2015-07-28 Bayer Healthcare Llc Analyte-testing device
US8945930B2 (en) 2007-01-23 2015-02-03 Bayer Healthcare Llc Analyte-testing device
US8309357B2 (en) * 2007-01-23 2012-11-13 Bayer Healthcare, Llc Analyte-testing device
US8679847B2 (en) 2007-01-23 2014-03-25 Bayer Healthcare Llc Analyte-testing device
US20100049013A1 (en) * 2007-01-23 2010-02-25 Kevin Chang Analyte-testing device
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US20080201325A1 (en) * 2007-02-18 2008-08-21 Abbott Diabetes Care, Inc. Method And System For Providing Contextual Based Medication Dosage Determination
US9801545B2 (en) 2007-03-01 2017-10-31 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9095290B2 (en) 2007-03-01 2015-08-04 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9649057B2 (en) 2007-05-08 2017-05-16 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8362904B2 (en) 2007-05-08 2013-01-29 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US20090318789A1 (en) * 2007-05-08 2009-12-24 Fennell Martin J Analyte Monitoring System and Methods
US9000929B2 (en) 2007-05-08 2015-04-07 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9314198B2 (en) 2007-05-08 2016-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10653317B2 (en) 2007-05-08 2020-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9574914B2 (en) 2007-05-08 2017-02-21 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9035767B2 (en) 2007-05-08 2015-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US20090318792A1 (en) * 2007-05-08 2009-12-24 Fennell Martin J Analyte Monitoring System and Methods
US8593287B2 (en) 2007-05-08 2013-11-26 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US20080281840A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US9177456B2 (en) 2007-05-08 2015-11-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10178954B2 (en) 2007-05-08 2019-01-15 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8149117B2 (en) 2007-05-08 2012-04-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US20080278333A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US11696684B2 (en) 2007-05-08 2023-07-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US20100014626A1 (en) * 2007-05-08 2010-01-21 Fennell Martin J Method And Device For Determining Elapsed Sensor Life
US10952611B2 (en) 2007-05-08 2021-03-23 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9949678B2 (en) 2007-05-08 2018-04-24 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US10690614B2 (en) 2007-12-10 2020-06-23 Ascensia Diabetes Care Holdings Ag Method of using an electrochemical test sensor
US9933385B2 (en) 2007-12-10 2018-04-03 Ascensia Diabetes Care Holdings Ag Method of using an electrochemical test sensor
US20100191472A1 (en) * 2009-01-29 2010-07-29 Abbott Diabetes Care, Inc. Method and Device for Early Signal Attenuation Using Blood Glucose Measurements
US8676513B2 (en) 2009-01-29 2014-03-18 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8473220B2 (en) 2009-01-29 2013-06-25 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US9066709B2 (en) 2009-01-29 2015-06-30 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US20100275108A1 (en) * 2009-04-28 2010-10-28 Abbott Diabetes Care Inc. Error Detection in Critical Repeating Data in a Wireless Sensor System
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US10360422B2 (en) 2009-05-14 2019-07-23 Ascensia Diabetes Care Holdings Ag Calibration coded sensors and apparatus, systems and methods for reading same
US9378443B2 (en) 2009-05-14 2016-06-28 Ascensia Diabetes Care Holding Ag Calibration coded sensors and apparatus, systems and methods for reading same
US20100288841A1 (en) * 2009-05-14 2010-11-18 Bayer Healthcare Llc Calibration coded sensors and apparatus, systems and methods for reading same
US11872370B2 (en) 2009-05-29 2024-01-16 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US11793936B2 (en) 2009-05-29 2023-10-24 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US8700845B1 (en) * 2009-08-12 2014-04-15 Micron Technology, Inc. Daisy chaining nonvolatile memories
US11150145B2 (en) 2009-08-31 2021-10-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US10429250B2 (en) 2009-08-31 2019-10-01 Abbott Diabetes Care, Inc. Analyte monitoring system and methods for managing power and noise
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US11045147B2 (en) 2009-08-31 2021-06-29 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9968302B2 (en) 2009-08-31 2018-05-15 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US11635332B2 (en) 2009-08-31 2023-04-25 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US9750439B2 (en) 2009-09-29 2017-09-05 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US10349874B2 (en) 2009-09-29 2019-07-16 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US20110077494A1 (en) * 2009-09-29 2011-03-31 Abbott Diabetes Care Inc. Method and Apparatus for Providing Notification Function in Analyte Monitoring Systems
US11516443B2 (en) 2010-04-30 2022-11-29 Becton, Dickinson And Company System and method for acquiring images of medication preparations
US10554937B2 (en) 2010-04-30 2020-02-04 Becton, Dickinson And Company System and method for acquiring images of medication preparations
US11838690B2 (en) 2010-04-30 2023-12-05 Becton, Dickinson And Company System and method for acquiring images of medication preparations
US10412347B2 (en) 2010-04-30 2019-09-10 Becton, Dickinson And Company System and method for acquiring images of medication preparation
US9930297B2 (en) 2010-04-30 2018-03-27 Becton, Dickinson And Company System and method for acquiring images of medication preparations
US9632055B2 (en) 2010-11-12 2017-04-25 Ascensia Diabetes Care Holdings Ag Auto-coded analyte sensors and apparatus, systems, and methods for detecting same
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9915616B2 (en) * 2012-07-10 2018-03-13 Fgroupip1, Llc Method to identify chemical compounds using colorimetric spot tests
US20140017802A1 (en) * 2012-07-10 2014-01-16 Fgroupip1, Llc Method to identify chemical compounds using colorimetric spot tests
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US11612363B2 (en) 2012-09-17 2023-03-28 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9068968B2 (en) 2013-07-02 2015-06-30 Daniel Gordon DRURY Urine analysis device, method and system
US11568537B2 (en) 2014-09-08 2023-01-31 Becton, Dickinson And Company Enhanced platen for pharmaceutical compounding
US11763448B2 (en) 2014-09-08 2023-09-19 Becton, Dickinson And Company System and method for preparing a pharmaceutical compound
US10679342B2 (en) 2014-09-08 2020-06-09 Becton, Dickinson And Company Aerodynamically streamlined enclosure for input devices of a medication preparation system
US10853938B2 (en) 2014-09-08 2020-12-01 Becton, Dickinson And Company Enhanced platen for pharmaceutical compounding
US11341641B2 (en) 2014-09-08 2022-05-24 Becton, Dickinson And Company Aerodynamically streamlined enclosure for input devices of a medication preparation system
US10692207B2 (en) 2014-09-08 2020-06-23 Becton, Dickinson And Company System and method for preparing a pharmaceutical compound

Also Published As

Publication number Publication date
WO1992001989A1 (en) 1992-02-06

Similar Documents

Publication Publication Date Title
US5182707A (en) Apparatus for recording reagent test strip data by comparison to color lights on a reference panel
US5665215A (en) Method and apparatus for making predetermined events with a biosensor
US5415840A (en) Liquid sample automatic analyzer
JP2755823B2 (en) Monitor device
EP1066530B1 (en) Test methods, devices and test kits for fertility
US5019974A (en) Diabetes management system and apparatus
EP1611500B1 (en) Method and system for transferring analyte test data
EP0656122B1 (en) Contraceptive methods and test kits for use therein
GB2339615A (en) Immunoassay testing
JP2009543041A (en) Disposable analyzer and analysis method
RU2146059C1 (en) Method for controlling the current ovulation cycle state
JPH02278142A (en) Portable optical analyzer for reading reagent patch and method for operating the same
US20070015285A1 (en) Test methods, devices and test kits
WO2008078128A1 (en) A portable blood analyzer for measuring the level of at least one compound contained in the blood of a patient
CN219871365U (en) Tray for parallel processing of multiple test devices
US11070965B2 (en) Method and system for linking devices
JPS6318253A (en) Biochemical measuring apparatus
GB2335983A (en) Estimating time of maximum fertility
JPS6252464A (en) Biochemical measuring apparatus
AU5356400A (en) Monitoring method

Legal Events

Date Code Title Description
AS Assignment

Owner name: HEALTHDYNE, INC., 1850 PARKWAY PLACE, 12TH FLOOR,

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:COOPER, TOMMY G.;SMITH, ROSS E.;MACHA, EMIL S.;REEL/FRAME:005468/0824;SIGNING DATES FROM 19900918 TO 19900926

Owner name: HEALTHDYNE INC., GEORGIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:COOPER, TOMMY G.;SMITH, ROSS E.;MACHA, EMIL S.;REEL/FRAME:005454/0284;SIGNING DATES FROM 19900918 TO 19900926

STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: CONTINENTAL BANK, N.A., ILLINOIS

Free format text: SECURITY INTEREST;ASSIGNOR:HEALTHDYNE TECHNOLOGIES, INC.;REEL/FRAME:006611/0362

Effective date: 19930629

AS Assignment

Owner name: HEALTHDYNE TECHNOLOGIES, INC., GEORGIA

Free format text: RELEASE OF PATENT & TRADEMARK SECURITY AGREEMENT;ASSIGNOR:CONTINENTAL BANK, N.A.;REEL/FRAME:007365/0420

Effective date: 19941229

Owner name: BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIA

Free format text: AMENDED AND RESTATED PATENT AND TRADEMARK SECURITY AGREEMENT;ASSIGNOR:HEALTHDYNE TECHNOLOGIES, INC.;REEL/FRAME:007365/0425

Effective date: 19941229

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: RESPIRONICS GEORGIA, INC., GEORGIA

Free format text: CHANGE OF NAME;ASSIGNOR:HEALTHDYNE TECHNOLOGIES, INC.;REEL/FRAME:010996/0221

Effective date: 19980421

AS Assignment

Owner name: MATRIA HEALTHCARE, INC., GEORGIA

Free format text: RELEASE OF SECURITY AGREEMENT;ASSIGNOR:WACHOVIA BANK, NATIONAL ASSOCIATION F/K/A FIRST UNION NATIONAL BANK, AS AGENT;REEL/FRAME:013429/0380

Effective date: 20021017

FPAY Fee payment

Year of fee payment: 12

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

AS Assignment

Owner name: MATRIA HEALTHCARE, INC., GEORGIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RESPIRONICS GEORGIA, INC., FORMERLY KNOWN AS HEALTHDYNE TECHNOLOGIES, INC.;REEL/FRAME:017164/0883

Effective date: 20010223

AS Assignment

Owner name: BANK OF AMERICA, N.A., AS COLLATERAL AGENT,ILLINOI

Free format text: NOTICE OF GRANT OF SECURITY INTEREST;ASSIGNOR:MATRIA HEALTHCARE, INC.;REEL/FRAME:017215/0690

Effective date: 20060119

Owner name: BANK OF AMERICA, N.A., AS COLLATERAL AGENT, ILLINO

Free format text: NOTICE OF GRANT OF SECURITY INTEREST;ASSIGNOR:MATRIA HEALTHCARE, INC.;REEL/FRAME:017215/0690

Effective date: 20060119

AS Assignment

Owner name: BANK OF AMERICA, N.A., AS COLLATERAL AGENT,ILLINOI

Free format text: NOTICE OF GRANT OF SECURITY INTEREST;ASSIGNOR:MATRIA HEALTHCARE, INC.;REEL/FRAME:017366/0756

Effective date: 20060119

Owner name: BANK OF AMERICA, N.A., AS COLLATERAL AGENT, ILLINO

Free format text: NOTICE OF GRANT OF SECURITY INTEREST;ASSIGNOR:MATRIA HEALTHCARE, INC.;REEL/FRAME:017366/0756

Effective date: 20060119

AS Assignment

Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT, MA

Free format text: SECURITY AGREEMENT;ASSIGNOR:MATRIA HEALTHCARE, LLC;REEL/FRAME:021147/0201

Effective date: 20070626

Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT,MAR

Free format text: SECURITY AGREEMENT;ASSIGNOR:MATRIA HEALTHCARE, LLC;REEL/FRAME:021147/0201

Effective date: 20070626

AS Assignment

Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT, MA

Free format text: SECURITY AGREEMENT;ASSIGNOR:MATRIA HEALTHCARE, LLC;REEL/FRAME:021185/0459

Effective date: 20070626

Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT,MAR

Free format text: SECURITY AGREEMENT;ASSIGNOR:MATRIA HEALTHCARE, LLC;REEL/FRAME:021185/0459

Effective date: 20070626

AS Assignment

Owner name: MATRIA HEALTHCARE, LLC, GEORGIA

Free format text: MERGER;ASSIGNOR:MATRIA HEALTHCARE, INC.;REEL/FRAME:021936/0510

Effective date: 20080509

Owner name: MATRIA HEALTHCARE, LLC,GEORGIA

Free format text: MERGER;ASSIGNOR:MATRIA HEALTHCARE, INC.;REEL/FRAME:021936/0510

Effective date: 20080509

AS Assignment

Owner name: MATRIA HEALTHCARE, LLC, GEORGIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:022214/0639

Effective date: 20080509

Owner name: MATRIA HEALTHCARE, LLC,GEORGIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:022214/0639

Effective date: 20080509

AS Assignment

Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, MARYLAND

Free format text: SECURITY AGREEMENT;ASSIGNORS:ADVANTAGE DIAGNOSTICS CORPORATION;ALERE MEDICAL INCORPORATED;ALERE SAN DIEGO, INC.;AND OTHERS;REEL/FRAME:026557/0287

Effective date: 20110630

AS Assignment

Owner name: GENECARE MEDICAL GENETICS CENTER, INC., NORTH CARO

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: ALERE MEDICAL, INC., NEVADA

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: INVERNESS MEDICAL - BIOSTAR INC., MASSACHUSETTS

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: CHOLESTECH CORPORATION, CALIFORNIA

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: BIOSITE INCORPORATED, CALIFORNIA

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: APPLIED BIOTECH, INC., CALIFORNIA

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: ADVANTAGE DIAGNOSTICS CORPORATION, CALIFORNIA

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: MATRIA HEALTHCARE, INC., GEORGIA

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: ALERE SAN DIEGO, INC., CALIFORNIA

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: HEMOSENSE, INC., CALIFORNIA

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: MATRITECH, INC., MASSACHUSETTS

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: AMEDITECH INC., CALIFORNIA

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: INSTANT TECHNOLOGIES, INC., VIRGINIA

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: ZYCARE, INC., NORTH CAROLINA

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: ISCHEMIA TECHNOLOGIES, INC., MASSACHUSETTS

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: ALERE SCARBOROUGH, INC., MAINE

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618

Owner name: BINAX, INC., MAINE

Free format text: NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT;REEL/FRAME:036011/0581

Effective date: 20150618